AKT2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O14492 | S598 | SIGNOR | SH2B2 APS | SGPAPPRPVEGQLSARsRsNsAERLLEAVAATAAEEPPEAA |
| O14579 | S99 | Sugiyama | COPE | PELQAVRMFADyLAHEsRRDsIVAELDREMsRSVDVTNTTF |
| O14746 | S227 | SIGNOR|ELM | TERT EST2 TCS1 TRT | VREAGVPLGLPAPGARRRGGsASRSLPLPKRPRRGAAPEPE |
| O14746 | S824 | SIGNOR|ELM | TERT EST2 TCS1 TRT | GLFDVFLRFMCHHAVRIRGKsYVQCQGIPQGSILSTLLCSL |
| O14757 | S280 | SIGNOR|ELM | CHEK1 CHK1 | KKDRWYNKPLKKGAKRPRVtsGGVsEsPsGFsKHIQsNLDF |
| O14776 | T746 | Sugiyama | TCERG1 CA150 TAF2S | MQAKEDFKKMMEEAKFNPRAtFSEFAAKHAKDSRFKAIEKM |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15013 | S1287 | Sugiyama | ARHGEF10 KIAA0294 | WLGDSLGSMTQKsDLssssGsLsLsHGsssLEHRSEDsTIy |
| O15111 | T23 | SIGNOR|ELM|iPTMNet|EPSD|PSP | CHUK IKKA TCF16 | RPPGLRPGAGGPWEMRERLGtGGFGNVCLYQHRELDLKIAI |
| O15119 | S719 | SIGNOR | TBX3 | LSsssMsLsPKLCAEKEAATsELQsIQRLVSGLEAKPDRsR |
| O15143 | S328 | Sugiyama | ARPC1B ARC41 | KAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTT |
| O15151 | S367 | SIGNOR | MDM4 MDMX | tAIPEKENEGNDVPDCRRtIsAPVVRPKDAYIKKENSKLFD |
| O15360 | S1149 | SIGNOR|ELM | FANCA FAA FACA FANCH | DITAHFFRGLLNACLRSRDPsLMVDFILAKCQTKCPLILTS |
| O15519 | S273 | SIGNOR | CFLAR CASH CASP8AP1 CLARP MRIT | ICLIIDCIGNETELLRDTFTsLGYEVQKFLHLSMHGISQIL |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43464 | S212 | SIGNOR|EPSD|PSP | HTRA2 OMI PRSS25 | LIVTNAHVVADRRRVRVRLLsGDtYEAVVTAVDPVADIATL |
| O43516 | S154 | EPSD|PSP | WIPF1 WASPIP WIP | RSTsAKPFsPPSGPGRFPVPsPGHRSGPPEPQRNRMPPPRP |
| O43516 | T398 | EPSD|PSP | WIPF1 WASPIP WIP | PLPPPPPVSRNGSTSRALPAtPQLPSRSGVDsPRsGPRPPL |
| O43521 | S87 | SIGNOR | BCL2L11 BIM | PAsPGPFATRsPLFIFMRRSsLLSRsssGYFsFDTDRsPAP |
| O43524 | S253 | SIGNOR|ELM | FOXO3 FKHRL1 FOXO3A | WWIINPDGGKsGKAPRRRAVsMDNsNKYTKSRGRAAKKKAA |
| O43524 | S315 | SIGNOR | FOXO3 FKHRL1 FOXO3A | PtSRssDELDAWTDFRsRTNsNAsTVsGRLSPIMAsTELDE |
| O43524 | T32 | SIGNOR|ELM | FOXO3 FKHRL1 FOXO3A | sPLEVELDPEFEPQSRPRsCtWPLQRPELQAsPAKPSGETA |
| O43707 | T69 | Sugiyama | ACTN4 | EKQQRKTFTAWCNsHLRKAGtQIENIDEDFRDGLKLMLLLE |
| O60285 | S600 | SIGNOR|ELM | NUAK1 ARK5 KIAA0537 OMPHK1 | SDSFDLLDLQENRPARQRIRsCVsAENFLQIQDFEGLQNRP |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60331 | S555 | EPSD|PSP | PIP5K1C KIAA0589 | IPERSPsETSEQPRYRRRtQssGQDGRPQEEPPAEEDLQQI |
| O60343 | S588 | SIGNOR|Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60343 | T642 | SIGNOR|ELM | TBC1D4 AS160 KIAA0603 | AWQTFPEEDSDSPQFRRRAHtFsHPPsstKRKLNLQDGRAQ |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60343 | T752 | Sugiyama | TBC1D4 AS160 KIAA0603 | IRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRISW |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60825 | S466 | SIGNOR|ELM | PFKFB2 | RDKPTNNFPKNQTPVRMRRNsFtPLsssNtIRRPRNYsVGs |
| O60825 | S483 | SIGNOR|ELM | PFKFB2 | RRNsFtPLsssNtIRRPRNYsVGsRPLKPLsPLRAQDMQEG |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O75369 | S1442 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | SKVKIAGPGLGsGVRARVLQsFtVDSSKAGLAPLEVRVLGP |
| O75376 | S1450 | SIGNOR | NCOR1 KIAA1047 | VERGKYEDVKAGETVRSRHtsVVsSGPSVLRSTLHEAPKAQ |
| O75665 | S899 | Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O75937 | S81 | Sugiyama | DNAJC8 SPF31 HSPC315 HSPC331 | VLQIDPEVTDEEIKKRFRQLsILVHPDKNQDDADRAQKAFE |
| O94992 | T270 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | GGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELIKE |
| O95453 | S557 | Sugiyama | PARN DAN | KRLNPQCIPYTLQNHYYRNNsFtAPstVGKRNLsPsQEEAG |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95835 | S464 | Sugiyama | LATS1 WARTS | SPSSGHEIPTWQPNIPVRsNsFNNPLGNRASHSANSQPSAT |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00533 | S229 | PSP | EGFR ERBB ERBB1 HER1 | KLTKIICAQQCSGRCRGKSPsDCCHNQCAAGCTGPRESDCL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P03372 | S104 | SIGNOR | ESR1 ESR NR3A1 | SEAAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPH |
| P03372 | S106 | SIGNOR | ESR1 ESR NR3A1 | AAAFGSNGLGGFPPLNsVsPsPLMLLHPPPQLsPFLQPHGQ |
| P03372 | S118 | SIGNOR | ESR1 ESR NR3A1 | PPLNsVsPsPLMLLHPPPQLsPFLQPHGQQVPYYLENEPSG |
| P03372 | S167 | SIGNOR|ELM|iPTMNet|EPSD|PSP | ESR1 ESR NR3A1 | PAFYRPNsDNRRQGGRERLAsTNDKGSMAMESAKETRYCAV |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04049 | S259 | SIGNOR|ELM | RAF1 RAF | tFNtssPSSEGSLSQRQRststPNVHMVsttLPVDSRMIED |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04150 | S134 | SIGNOR | NR3C1 GRL | SGETDLKLLEEsIANLNRstsVPENPKSSASTAVSAAPTEK |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | EPSD|PSP | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S82 | SIGNOR|Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05106 | T779 | SIGNOR | ITGB3 GP3A | ERARAKWDtANNPLyKEAtstFtNItyRGt___________ |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07550 | S345 | SIGNOR | ADRB2 ADRB2R B2AR | IyCRSPDFRIAFQELLCLRRssLKAyGNGyssNGNtGEQsG |
| P07550 | S346 | SIGNOR|ELM | ADRB2 ADRB2R B2AR | yCRSPDFRIAFQELLCLRRssLKAyGNGyssNGNtGEQsGY |
| P07814 | S1336 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | SEEDKEALIAKCNDYRRRLLsVNIRVRADLRDNysPGWKFN |
| P07814 | S999 | PSP | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | QKQNDGQRKDPsKNQGGGLsssGAGEGQGPKKQTRLGLEAK |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08174 | T102 | Sugiyama | CD55 CR DAF | LKGSQWSDIEEFCNRSCEVPtRLNsAsLKQPYITQNyFPVG |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08670 | S39 | SIGNOR | VIM | GtAsRPsssRsYVttsTRtYsLGsALRPstsRsLyAssPGG |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09601 | S188 | SIGNOR | HMOX1 HO HO1 | TFPNIASATKFKQLYRSRMNsLEMTPAVRQRVIEEAKTAFL |
| P09651 | S199 | SIGNOR | HNRNPA1 HNRPA1 | KALSKQEMAsAsssQRGRsGsGNFGGGRGGGFGGNDNFGRG |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0C0L4 | S1567 | Sugiyama | C4A CO4 CPAMD2 | GLVQPASATLYDYYNPERRCsVFYGAPSKSRLLATLCSAEV |
| P0C0L5 | S1567 | Sugiyama | C4B CO4 CPAMD3; C4B_2 | GLVQPASATLYDYYNPERRCsVFYGAPSKSRLLATLCSAEV |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10275 | S215 | SIGNOR | AR DHTR NR3C4 | QQQQQEAVSEGssSGRAREAsGAPTsSKDNyLGGTSTISDN |
| P10275 | S792 | SIGNOR | AR DHTR NR3C4 | NEYRMHKSRMYSQCVRMRHLsQEFGWLQITPQEFLCMKALL |
| P10276 | S96 | SIGNOR | RARA NR1B1 | PsPPPLPRIYKPCFVCQDKSsGYHYGVSACEGCKGFFRRSI |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12755 | T458 | SIGNOR | SKI | AVSRAPEPLATCTQPRKRKLtVDTPGAPETLAPVAAPEEDK |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13674 | T364 | Sugiyama | P4HA1 P4HA | IsDAEIEIVKDLAKPRLRRAtIsNPITGDLETVHYRISKsA |
| P13797 | S339 | Sugiyama | PLS3 | PRIDINMsGFNETDDLKRAEsMLQQADKLGCRQFVTPADVV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14598 | S304 | SIGNOR|ELM | NCF1 NOXO2 SH3PXD1A | GQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDAY |
| P14598 | S328 | SIGNOR|ELM | NCF1 NOXO2 SH3PXD1A | AHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQARPGPQsPGs |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P15056 | S364 | SIGNOR | BRAF BRAF1 RAFB1 | QPFRPADEDHRNQFGQRDRsssAPNVHINtIEPVNIDDLIR |
| P15056 | S365 | ELM | BRAF BRAF1 RAFB1 | PFRPADEDHRNQFGQRDRsssAPNVHINtIEPVNIDDLIRD |
| P15056 | S428 | SIGNOR | BRAF BRAF1 RAFB1 | GSLTNVKALQKsPGPQRERKsssssEDRNRMKtLGRRDssD |
| P15056 | S429 | ELM | BRAF BRAF1 RAFB1 | SLTNVKALQKsPGPQRERKsssssEDRNRMKtLGRRDssDD |
| P15056 | T440 | SIGNOR | BRAF BRAF1 RAFB1 | PGPQRERKsssssEDRNRMKtLGRRDssDDWEIPDGQITVG |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15311 | T567 | GPS6|SIGNOR|ELM|EPSD|PSP | EZR VIL2 | RTHNDIIHNENMRQGRDKYKtLRQIRQGNTKQRIDEFEAL_ |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P15976 | S310 | SIGNOR|ELM | GATA1 ERYF1 GF1 | QVNRPLTMRKDGIQTRNRKAsGKGKKKRGSSLGGTGAAEGP |
| P16220 | S119 | SIGNOR | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16930 | S165 | Sugiyama | FAH | ENALMPNWLHLPVGYHGRAssVVVSGTPIRRPMGQMKPDDS |
| P17542 | T90 | SIGNOR | TAL1 BHLHA17 SCL TCL5 | AARDLKGRDAATAEARHRVPtTELCRPPGPAPAPAPASVTA |
| P17655 | T464 | Sugiyama | CAPN2 CANPL2 | TNIHLSKNFFLTNRARERsDtFINLREVLNRFKLPPGEYIL |
| P18031 | S50 | SIGNOR|ELM | PTPN1 PTP1B | FPCRVAKLPKNKNRNRyRDVsPFDHSRIKLHQEDNDyINAs |
| P18583 | S2011 | Sugiyama | SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312 | RSRTPSRRRRSRSVVRRRsFsIsPVRLRRSRTPLRRRFsRs |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20749 | S41 | SIGNOR | BCL3 BCL4 D19S37 | KAAGLPGAALPLRKRPLRAPsPEPAAPRGAAGLVVPLDPLR |
| P21453 | T236 | SIGNOR|ELM | S1PR1 CHEDG1 EDG1 | SIVILYCRIYSLVRTRSRRLtFRKNISKASRSSEKSLALLK |
| P21731 | S331 | Sugiyama | TBXA2R | FRRAVLRRLQPRLsTRPRsLsLQPQLtQRSGLQ________ |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P22736 | S351 | SIGNOR|ELM | NR4A1 GFRP1 HMR NAK1 | GMVKEVVRTDsLKGRRGRLPsKPKQPPDAsPANLLtSLVRA |
| P23396 | T70 | SIGNOR | RPS3 OK/SW-cl.26 | ILATRTQNVLGEKGRRIRELtAVVQKRFGFPEGsVELyAEK |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | S422 | SIGNOR | EIF4B | ERHPsWRsEEtQERERsRtGsEssQtGtstTssRNARRREs |
| P23769 | S401 | SIGNOR | GATA2 | NVNRPLTMKKEGIQTRNRKMsNKSKKSKKGAECFEELSKCM |
| P24941 | T39 | SIGNOR | CDK2 CDKN2 | yKARNKLTGEVVALKKIRLDtETEGVPstAIREIsLLKELN |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P26358 | S143 | SIGNOR | DNMT1 AIM CXXC9 DNMT | ADANsPPKPLSKPRTPRRsKsDGEAKPEPsPsPRITRKSTR |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P26678 | T17 | SIGNOR | PLN PLB | ____MEKVQYLTRSAIRRAstIEMPQQARQKLQNLFINFCL |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P29401 | T382 | SIGNOR | TKT | CYIAEQNMVSIAVGCATRNRtVPFCsTFAAFFTRAFDQIRM |
| P29474 | S1177 | SIGNOR|ELM | NOS3 | EDIFGLTLRTQEVTSRIRtQsFsLQERQLRGAVPWAFDPPG |
| P29474 | S1179 | ELM | NOS3 | IFGLTLRTQEVTSRIRtQsFsLQERQLRGAVPWAFDPPGSD |
| P29474 | S615 | SIGNOR|ELM | NOS3 | GPYNSsPRPEQHKSYKIRFNsISCSDPLVssWRRKRKEssN |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30405 | S31 | SIGNOR|EPSD|PSP | PPIF CYP3 | LGLLSVPRSVPLRLPAARACsKGSGDPSssSSSGNPLVYLD |
| P31323 | S114 | ELM | PRKAR2B | APADAGAFNAPVINRFTRRAsVCAEAyNPDEEEDDAESRII |
| P31749 | T312 | Sugiyama | AKT1 PKB RAC | DFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGRAVDW |
| P31751 | S126 | Sugiyama | AKT2 | VANSLKQRAPGEDPMDyKCGsPsDssttEEMEVAVSKARAK |
| P31751 | S128 | Sugiyama | AKT2 | NSLKQRAPGEDPMDyKCGsPsDssttEEMEVAVSKARAKVT |
| P31751 | S130 | Sugiyama | AKT2 | LKQRAPGEDPMDyKCGsPsDssttEEMEVAVSKARAKVTMN |
| P31751 | S131 | Sugiyama | AKT2 | KQRAPGEDPMDyKCGsPsDssttEEMEVAVSKARAKVTMND |
| P31751 | S474 | Sugiyama | AKT2 | DRyDsLGLLELDQRTHFPQFsysAsIRE_____________ |
| P31751 | S476 | Sugiyama | AKT2 | yDsLGLLELDQRTHFPQFsysAsIRE_______________ |
| P31751 | S478 | Sugiyama | AKT2 | sLGLLELDQRTHFPQFsysAsIRE_________________ |
| P31751 | T313 | Sugiyama | AKT2 | DFGLCKEGISDGATMKtFCGtPEyLAPEVLEDNDyGRAVDW |
| P31751 | Y475 | Sugiyama | AKT2 | RyDsLGLLELDQRTHFPQFsysAsIRE______________ |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35222 | S552 | SIGNOR|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AIPRLVQLLVRAHQDtQRRtsMGGtQQQFVEGVRMEEIVEG |
| P35226 | S316 | SIGNOR|PSP | BMI1 PCGF4 RNF51 | TSNSPSGNHQSSFANRPRKSsVNGSSATSSG__________ |
| P35240 | S10 | PSP | NF2 SCH | ___________MAGAIASRMsFssLKRKQPKTFTVRIVTMD |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38398 | S694 | SIGNOR | BRCA1 RNF53 | PATGAKKSNKPNEQTSKRHDsDTFPELKLTNAPGsFtKCSN |
| P38398 | T509 | SIGNOR|ELM | BRCA1 RNF53 | EPQIIQERPLTNKLKRKRRPtsGLHPEDFIKKADLAVQKTP |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T111 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAFtADGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDP |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38936 | S146 | ELM | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | QAEGsPGGPGDSQGRKRRQtsMTDFYHsKRRLIFSKRKP__ |
| P38936 | T145 | SIGNOR|ELM | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | EQAEGsPGGPGDSQGRKRRQtsMTDFYHsKRRLIFSKRKP_ |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P40926 | T179 | Sugiyama | MDH2 | GVYNPNKIFGVTTLDIVRANtFVAELKGLDPARVNVPVIGG |
| P41002 | S577 | SIGNOR | CCNF FBX1 FBXO1 | EIHAFLSSPSGRRTKRKRENsLQEDRGSFVTtPtAELSSQE |
| P41002 | T31 | SIGNOR | CCNF FBX1 FBXO1 | CAKCFCYPTKRRIRRRPRNLtILSLPEDVLFHILKWLSVED |
| P41219 | S59 | SIGNOR | PRPH NEF4 PRPH1 | RFSSSRLLGsAsPsssVRLGsFRSPRAGAGALLRLPSERLD |
| P41279 | S400 | SIGNOR|ELM | MAP3K8 COT ESTF | ADLLKHEALNPPREDQPRCQsLDSALLERKRLLsRKELELP |
| P41279 | S413 | SIGNOR | MAP3K8 COT ESTF | EDQPRCQsLDSALLERKRLLsRKELELPENIADSSCTGSTE |
| P42345 | S2448 | SIGNOR|ELM | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | NWRLMDTNTKGNKRsRtRtDsYsAGQsVEILDGVELGEPAH |
| P42345 | T2446 | SIGNOR|ELM | MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 | LLNWRLMDTNTKGNKRsRtRtDsYsAGQsVEILDGVELGEP |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42858 | S419 | SIGNOR | HTT HD IT15 | GGIGQLtAAKEEsGGRsRsGsIVELIAGGGssCsPVLsRKQ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P45985 | S80 | SIGNOR|ELM | MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 | tLNPNPtGVQNPHIERLRTHsIEsSGKLKIsPEQHWDFtAE |
| P46527 | S10 | ELM | CDKN1B KIP1 p27 | ___________MSNVRVSNGsPsLERMDARQAEHPKPSACR |
| P46527 | T157 | SIGNOR|ELM | CDKN1B KIP1 p27 | PsDsQTGLAEQCAGIRKRPAtDDSSTQNKRANRTEENVsDG |
| P46527 | T198 | SIGNOR | CDKN1B KIP1 p27 | sPNAGSVEQtPKKPGLRRRQt____________________ |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46937 | S127 | SIGNOR|ELM | YAP1 YAP65 | QAstDAGtAGALtPQHVRAHssPAsLQLGAVsPGtLtPtGV |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47870 | S472 | SIGNOR | GABRB2 | GRNALERHVAQKKSRLRRRAsQLKITIPDLTDVNAIDRWSR |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49753 | T118 | Sugiyama | ACOT2 PTE2 PTE2A | ASLRDEKGALFQAHARyRADtLGELDLERAPALGGSFAGLE |
| P49760 | S34 | SIGNOR | CLK2 | SRGSYREHYRSRKHKRRRSRsWSSSSDRTRRRRREDsYHVR |
| P49760 | T127 | SIGNOR | CLK2 | SYRSQRSSRRKHRRRRRRSRtFSRSSSQHSSRRAKsVEDDA |
| P49815 | S939 | SIGNOR|ELM | TSC2 TSC4 | NVLLsFDDtPEKDsFRARsTsLNERPKSLRIARPPKQGLNN |
| P49815 | T1462 | SIGNOR|ELM | TSC2 TSC4 | EGPLPsssPRsPsGLRPRGYtIsDsAPsRRGKRVERDALKS |
| P49840 | S21 | SIGNOR|ELM|Sugiyama | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49841 | S9 | SIGNOR | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P49918 | S282 | SIGNOR | CDKN1C KIP2 | AAIKKLSGPLISDFFAKRKRsAPEKssGDVPAPCPsPsAAP |
| P49918 | T310 | SIGNOR | CDKN1C KIP2 | DVPAPCPsPsAAPGVGSVEQtPRKRLR______________ |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51617 | T100 | SIGNOR|ELM | IRAK1 IRAK | VADLVHILTHLQLLRARDIItAWHPPAPLPSPGTTAPRPSS |
| P51946 | T12 | Sugiyama | CCNH | _________MYHNsSQKRHWtFSsEEQLARLRADANRKFRC |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52789 | T473 | SIGNOR | HK2 | AAMVTAVAYRLADQHRARQKtLEHLQLSHDQLLEVKRRMKV |
| P53365 | S260 | SIGNOR|Sugiyama | ARFIP2 POR1 | TDLEELsLGPRDAGTRGRLEsAQATFQAHRDKYEKLRGDVA |
| P53396 | S455 | SIGNOR|EPSD|Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S459 | Sugiyama | ACLY | LNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMPQDsV |
| P53621 | T591 | Sugiyama | COPA | TRVKGNNVyCLDRECRPRVLtIDPTEFKFKLALINRKYDEV |
| P53804 | S378 | GPS6|SIGNOR | TTC3 DCRR1 RNF105 TPRD | ANKDPIKAFYENRAYTPRsLsAPIFTTSLNFVEKERDFRKI |
| P54253 | S775 | SIGNOR | ATXN1 ATX1 SCA1 | APFLTKIEPSKPAATRKRRWsAPESRKLEKSEDEPPLTLPK |
| P54578 | S432 | SIGNOR | USP14 TGT | SNNCGYYDLQAVLTHQGRSssSGHyVSWVKRKQDEWIKFDD |
| P55072 | S352 | SIGNOR | VCP HEL-220 HEL-S-70 | MDGLKQRAHVIVMAAtNRPNsIDPALRRFGRFDREVDIGIP |
| P55072 | S746 | SIGNOR | VCP HEL-220 HEL-S-70 | DPVPEIRRDHFEEAMRFARRsVsDNDIRKyEMFAQtLQQsR |
| P55072 | S748 | SIGNOR | VCP HEL-220 HEL-S-70 | VPEIRRDHFEEAMRFARRsVsDNDIRKyEMFAQtLQQsRGF |
| P55196 | S216 | Sugiyama | AFDN AF6 MLLT4 | SRLAAEVYKDMPETSFTRtIsNPEVVMKRRRQQKLEKRMQE |
| P55199 | S47 | Sugiyama | ELL C19orf17 | HVKLTDSALRAFESYRARQDsVSLRPSIRFQGSQGHISIPQ |
| P55211 | S196 | SIGNOR|ELM | CASP9 MCH6 | GLRTRTGsNIDCEKLRRRFssLHFMVEVKGDLTAKKMVLAL |
| P55265 | T1033 | SIGNOR|PSP | ADAR ADAR1 DSRAD G1P1 IFI4 | VESSDIVPTWDGIRLGERLRtMSCSDKILRWNVLGLQGALL |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57059 | S435 | SIGNOR | SIK1 SIK SNF1LK | WPLFFPVDASCSGVFRPRPVsPssLLDTAISEEARQGPGLE |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62280 | S74 | Sugiyama | RPS11 | tyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIVIRRDYLH |
| P62333 | S244 | Sugiyama | PSMC6 SUG2 | DHQPCIIFMDEIDAIGGRRFsEGTSADREIQRTLMELLNQM |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P63000 | S71 | SIGNOR|ELM | RAC1 TC25 MIG5 | VNLGLWDTAGQEDyDRLRPLsYPQTDVFLICFSLVSPASFE |
| P63104 | S58 | SIGNOR|ELM | YWHAZ | NEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQM |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P67809 | S102 | SIGNOR | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68400 | T13 | Sugiyama | CSNK2A1 CK2A1 | ________MSGPVPSRARVytDVNTHRPREYWDYESHVVEW |
| P68431 | S11 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P68431 | S29 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | RKstGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| P68431 | T46 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78362 | S494 | Sugiyama | SRPK2 | GSPLTEQEESSPSHDRSRtVsAsstGDLPKAKTRAADLLVN |
| P78362 | T492 | SIGNOR | SRPK2 | SEGSPLTEQEESSPSHDRSRtVsAsstGDLPKAKTRAADLL |
| P78371 | S260 | SIGNOR | CCT2 99D8.1 CCTB | ANtGMDtDKIKIFGsRVRVDstAKVAEIEHAEKEKMKEKVE |
| P78563 | T553 | SIGNOR|PSP | ADARB1 ADAR2 DRADA2 RED1 | VRSNASIQTWDGVLQGERLLtMSCSDKIARWNVVGIQGSLL |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84243 | S11 | SIGNOR | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | __________MARtKQTARKstGGKAPRKQLATKAARKsAP |
| P98170 | S87 | SIGNOR|ELM|iPTMNet|EPSD|PSP | XIAP API3 BIRC4 IAP3 | HAAVDRWQYGDSAVGRHRKVsPNCRFINGFYLENSATQSTN |
| P98177 | S197 | SIGNOR|ELM | FOXO4 AFX AFX1 MLLT7 | WWMLNPEGGKSGKAPRRRAAsMDSSSKLLRGRSKAPKKKPS |
| P98177 | S262 | SIGNOR|ELM | FOXO4 AFX AFX1 MLLT7 | PCSRNREEADMWTTFRPRSSsNAsSVsTRLSPLRPESEVLA |
| P98177 | T32 | SIGNOR|iPTMNet | FOXO4 AFX AFX1 MLLT7 | AAAIIDLDPDFEPQSRPRsCtWPLPRPEIANQPSEPPEVEP |
| P98177 | T451 | ELM | FOXO4 AFX AFX1 MLLT7 | LSMIAPPPVMASAPIPKALGtPVLtPPTEAASQDRMPQDLD |
| P99999 | Y47 | SIGNOR|PSP | CYCS CYC | HKTGPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLME |
| Q00266 | S180 | PSP | MAT1A AMS1 MATA1 | LNARMADLRRSGLLPWLRPDsKTQVTVQYMQDNGAVIPVRI |
| Q00266 | T202 | PSP | MAT1A AMS1 MATA1 | TQVTVQYMQDNGAVIPVRIHtIVISVQHNEDITLEEMRRAL |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q00613 | S230 | PSP | HSF1 HSTF1 | PLMLNDsGsAHSMPKYSRQFsLEHVHGSGPYSAPSPAYSSS |
| Q00613 | S326 | PSP | HSF1 HSTF1 | QsPRVEEAsPGRPssVDtLLsPtALIDsILREsEPAPAsVT |
| Q00987 | S166 | SIGNOR|ELM | MDM2 | KPSSSHLVSRPstSSRRRAIsEtEENsDELsGERQRKRHKs |
| Q00987 | S186 | SIGNOR|ELM | MDM2 | sEtEENsDELsGERQRKRHKsDsISLsFDESLALCVIREIC |
| Q00987 | S188 | SIGNOR|ELM | MDM2 | tEENsDELsGERQRKRHKsDsISLsFDESLALCVIREICCE |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01860 | T235 | SIGNOR | POU5F1 OCT3 OCT4 OTF3 | ENLQEICKAETLVQARKRKRtsIENRVRGNLENLFLQCPKP |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q04656 | S1424 | SIGNOR|EPSD|PSP | ATP7A MC1 MNK | SLFLKLYRKPTYESYELPARsQIGQKsPsEIsVHVGIDDts |
| Q04656 | S1463 | SIGNOR|EPSD|PSP | ATP7A MC1 MNK | tsRNsPKLGLLDRIVNYsRAsINsLLsDKRsLNsVVTsEPD |
| Q04656 | S1466 | SIGNOR|EPSD|PSP | ATP7A MC1 MNK | NsPKLGLLDRIVNYsRAsINsLLsDKRsLNsVVTsEPDKHS |
| Q04912 | S1394 | SIGNOR|ELM | MST1R PTK8 RON | RPEQPQFSPMPGNVRRPRPLsEPPRPT______________ |
| Q05195 | S145 | SIGNOR | MXD1 MAD | EQRHLKRQLEKLGIERIRMDsIGSTVSSERSDSDREEIDVD |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07352 | S92 | SIGNOR|ELM | ZFP36L1 BERG36 BRF1 ERF1 RNF162B TIS11B | KGEPAPALSSRDsRFRDRsFsEGGERLLPTQKQPGGGQVNS |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07812 | S184 | SIGNOR | BAX BCL2L4 | YFGtPTWQtVtIFVAGVLTAsLtIWKKMG____________ |
| Q09472 | S1834 | SIGNOR|ELM | EP300 P300 | RQQQLQHRLQQAQMLRRRMAsMQRTGVVGQQQGLPSPTPAT |
| Q12778 | S256 | SIGNOR|ELM | FOXO1 FKHR FOXO1A | WWMLNPEGGKSGKsPRRRAAsMDNNSKFAKSRSRAAKKKAs |
| Q12778 | S319 | SIGNOR|ELM | FOXO1 FKHR FOXO1A | PGsHsNDDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLG |
| Q12778 | S322 | ELM | FOXO1 FKHR FOXO1A | HsNDDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLGEGD |
| Q12778 | S325 | ELM | FOXO1 FKHR FOXO1A | DDFDNWSTFRPRtssNAstIsGRLsPIMtEQDDLGEGDVHS |
| Q12778 | T24 | SIGNOR|ELM|EPSD | FOXO1 FKHR FOXO1A | APQVVEIDPDFEPLPRPRsCtWPLPRPEFSQSNSATSSPAP |
| Q12906 | S647 | SIGNOR | ILF3 DRBF MPHOSPH4 NF90 | GPMHNEVPPPPNLRGRGRGGsIRGRGRGRGFGGANHGGYMN |
| Q12931 | T494 | Sugiyama | TRAP1 HSP75 HSPC5 | ALPsGQLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyy |
| Q12965 | T936 | Sugiyama | MYO1E MYO1C | LQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAP |
| Q12965 | Y941 | Sugiyama | MYO1E MYO1C | GPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGy |
| Q12982 | S114 | Sugiyama | BNIP2 NIP2 | EFEWEDDLPKPKTTEVIRKGsItEyTAAEEKEDGRRWRMFR |
| Q13043 | T120 | SIGNOR | STK4 KRS2 MST1 | IVMEYCGAGSVSDIIRLRNKtLtEDEIAtILQStLKGLEYL |
| Q13043 | T387 | SIGNOR | STK4 KRS2 MST1 | tMVINAEDEEEEGtMKRRDEtMQPAKPsFLEyFEQKEKENQ |
| Q13188 | T117 | SIGNOR | STK3 KRS1 MST2 | IVMEYCGAGSVSDIIRLRNKtLIEDEIATILKSTLKGLEYL |
| Q13188 | T384 | SIGNOR | STK3 KRS1 MST2 | TMVINSEDEEEEDGtMKRNAtsPQVQRPsFMDyFDKQDFKN |
| Q13243 | S86 | SIGNOR | SRSF5 HRS SFRS5 SRP40 | RVTIEHARARSRGGRGRGRYsDRFsSRRPRNDRRNAPPVRT |
| Q13370 | S295 | SIGNOR | PDE3B | HPRLssAAEEKVPVIRPRRRssCVsLGETAASYYGSCKIFR |
| Q13370 | S318 | SIGNOR | PDE3B | VsLGETAASYYGSCKIFRRPsLPCISREQMILWDWDLKQWY |
| Q13439 | S41 | Sugiyama | GOLGA4 | APAQAssNsstPtRMRsRtssFtEQLDEGtPNRESGDTQSF |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13464 | S479 | Sugiyama | ROCK1 | KLDKIMKELDEEGNQRRNLEsTVsQIEKEKMLLQHRINEYQ |
| Q13480 | T387 | Sugiyama | GAB1 | sDTDssyCIPtAGMsPSRSNtIstVDLNKLRKDAssQDCyD |
| Q13610 | S485 | Sugiyama | PWP1 | SVNEAFGRRERLVLGSARNssISGPFGsRssDTPMES____ |
| Q13835 | S118 | SIGNOR|PSP | PKP1 | SWGYPIyNGTLKREPDNRRFssysQMENWsRHYPRGsCNTT |
| Q13835 | S119 | PSP | PKP1 | WGYPIyNGTLKREPDNRRFssysQMENWsRHYPRGsCNTTG |
| Q13835 | S121 | PSP | PKP1 | YPIyNGTLKREPDNRRFssysQMENWsRHYPRGsCNTTGAG |
| Q13835 | S127 | PSP | PKP1 | TLKREPDNRRFssysQMENWsRHYPRGsCNTTGAGsDICFM |
| Q13835 | S174 | SIGNOR|PSP | PKP1 | RsEPDLyCDPRGtLRKGtLGsKGQKttQNRysFystCsGQK |
| Q13835 | S185 | SIGNOR|PSP | PKP1 | GtLRKGtLGsKGQKttQNRysFystCsGQKAIKKCPVRPPs |
| Q13835 | S188 | SIGNOR|PSP | PKP1 | RKGtLGsKGQKttQNRysFystCsGQKAIKKCPVRPPsCAs |
| Q13835 | S191 | SIGNOR|PSP | PKP1 | tLGsKGQKttQNRysFystCsGQKAIKKCPVRPPsCAsKQD |
| Q13835 | S54 | PSP | PKP1 | GTSGRQRVQEQVMMTVKRQKsKssQsstLsHsNRGsMyDGL |
| Q13835 | S56 | PSP | PKP1 | SGRQRVQEQVMMTVKRQKsKssQsstLsHsNRGsMyDGLAD |
| Q13835 | S57 | PSP | PKP1 | GRQRVQEQVMMTVKRQKsKssQsstLsHsNRGsMyDGLADN |
| Q13835 | S59 | PSP | PKP1 | QRVQEQVMMTVKRQKsKssQsstLsHsNRGsMyDGLADNyN |
| Q13835 | S60 | PSP | PKP1 | RVQEQVMMTVKRQKsKssQsstLsHsNRGsMyDGLADNyNy |
| Q13835 | S63 | PSP | PKP1 | EQVMMTVKRQKsKssQsstLsHsNRGsMyDGLADNyNyGtT |
| Q13835 | S65 | PSP | PKP1 | VMMTVKRQKsKssQsstLsHsNRGsMyDGLADNyNyGtTsR |
| Q13835 | S69 | PSP | PKP1 | VKRQKsKssQsstLsHsNRGsMyDGLADNyNyGtTsRSSYY |
| Q13835 | S84 | PSP | PKP1 | HsNRGsMyDGLADNyNyGtTsRSSYYSKFQAGNGSWGYPIy |
| Q13835 | T166 | SIGNOR|PSP | PKP1 | FMQKIKAsRsEPDLyCDPRGtLRKGtLGsKGQKttQNRysF |
| Q13835 | T171 | SIGNOR|PSP | PKP1 | KAsRsEPDLyCDPRGtLRKGtLGsKGQKttQNRysFystCs |
| Q13835 | T179 | SIGNOR|PSP | PKP1 | LyCDPRGtLRKGtLGsKGQKttQNRysFystCsGQKAIKKC |
| Q13835 | T180 | SIGNOR|PSP | PKP1 | yCDPRGtLRKGtLGsKGQKttQNRysFystCsGQKAIKKCP |
| Q13835 | T189 | SIGNOR|PSP | PKP1 | KGtLGsKGQKttQNRysFystCsGQKAIKKCPVRPPsCAsK |
| Q13835 | T61 | PSP | PKP1 | VQEQVMMTVKRQKsKssQsstLsHsNRGsMyDGLADNyNyG |
| Q13835 | T82 | PSP | PKP1 | LsHsNRGsMyDGLADNyNyGtTsRSSYYSKFQAGNGSWGYP |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14153 | S167 | Sugiyama | FAM53B KIAA0140 SMP | YsGGsVQRYSNGFSTMQRsssFSLPSRANVLssPCDQAGLH |
| Q14204 | S4162 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | GRIFVFEPPPGVKANMLRTFssIPVSRICKSPNERARLYFL |
| Q14204 | S4368 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | MLEDEDDLAyAETEKKTRtDstsDGRPAWMRTLHTTASNWL |
| Q14315 | S2233 | SIGNOR|EPSD|PSP | FLNC ABPL FLN2 | VGGDPFPAVFGDFLGRERLGsFGsITRQQEGEAsSQDMTAQ |
| Q14566 | S498 | Sugiyama | MCM6 | EQQTISITKAGVKATLNARTsILAAANPIsGHyDRSKSLKQ |
| Q14653 | S14 | PSP | IRF3 | _______MGTPKPRILPWLVsQLDLGQLEGVAWVNKSRTRF |
| Q14653 | S175 | PSP | IRF3 | PGPPSLAVAPEPCPQPLRsPsLDNPtPFPNLGPsENPLKRL |
| Q14653 | T180 | PSP | IRF3 | LAVAPEPCPQPLRsPsLDNPtPFPNLGPsENPLKRLLVPGE |
| Q14653 | T207 | PSP | IRF3 | PsENPLKRLLVPGEEWEFEVtAFYRGRQVFQQTISCPEGLR |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14847 | S146 | Sugiyama | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14957 | S1081 | SIGNOR | GRIN2C NMDAR2C | ARREALLHAAWARGSRPRHAsLPSSVAEAFARPSSLPAGCT |
| Q14978 | S686 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KGKSFRHEKTKKKRGsYRGGsIsVQVNsIKFDsE_______ |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15027 | S554 | SIGNOR|ELM | ACAP1 CENTB1 KIAA0050 | GRPRGQPPVPPKPSIRPRPGsLRSKPEPPSEDLGSLHPGAL |
| Q15084 | S377 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | PAMAAINARKMKFALLKGsFsEQGINEFLRELsFGRGstAP |
| Q15118 | T346 | SIGNOR|EPSD|PSP | PDK1 PDHK1 | RKIDRLFNYMYStAPRPRVEtSRAVPLAGFGYGLPISRLYA |
| Q15121 | S116 | SIGNOR|ELM | PEA15 | DtKLtRIPsAKKYKDIIRQPsEEEIIKLAPPPKKA______ |
| Q15149 | S4386 | Sugiyama | PLEC PLEC1 | ItEFADMLsGNAGGFRsRsssVGssssyPIsPAVsRtQLAs |
| Q15365 | S43 | SIGNOR | PCBP1 | KEVGsIIGKKGESVKRIREEsGARINIsEGNCPERIItLTG |
| Q15642 | S296 | Sugiyama | TRIP10 CIP4 STOT STP | FARPGDVEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRS |
| Q15672 | S42 | SIGNOR | TWIST1 BHLHA38 TWIST | EEPDRQQPPSGKRGGRKRRSsRRSAGGGAGPGGAAGGGVGG |
| Q15910 | S21 | SIGNOR | EZH2 KMT6 | MGQTGKKSEKGPVCWRKRVKsEYMRLRQLKRFRRADEVKSM |
| Q15942 | S142 | SIGNOR | ZYX | EEEGGPEAPIPPPPQPREKVssIDLEIDsLssLLDDMTKND |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16584 | S674 | SIGNOR|ELM | MAP3K11 MLK3 PTK1 SPRK | sLGLGRDLQPPGGPGRERGEsPTTPPTPTPAPCPTEPPPsP |
| Q16658 | T403 | PSP | FSCN1 FAN1 HSN SNL | RPIIVFRGEHGFIGCRKVTGtLDANRSSyDVFQLEFNDGAy |
| Q16763 | T152 | Sugiyama | UBE2S E2EPF OK/SW-cl.73 | EAGRLLLENyEEyAARARLLtEIHGGAGGPSGRAEAGRALA |
| Q16875 | S461 | SIGNOR | PFKFB3 | THRERSEDAKKGPNPLMRRNsVtPLAsPEPtKKPRINsFEE |
| Q2PPJ7 | S486 | SIGNOR | RALGAPA2 C20orf74 KIAA1272 | KEASSESSGHKRSSsWGRtYsFTSAMSRGCVTEEENTNVKA |
| Q2PPJ7 | S696 | SIGNOR | RALGAPA2 C20orf74 KIAA1272 | QRGKGCVLDPQKGTTVGRSFsLSWRsHPDVTEPMRFRSAtT |
| Q2PPJ7 | T715 | SIGNOR | RALGAPA2 C20orf74 KIAA1272 | FsLSWRsHPDVTEPMRFRSAtTsGAPGVEKARNIVRQKATE |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3V6T2 | S1417 | SIGNOR | CCDC88A APE GRDN KIAA1212 | TLKMRKLIKSKKDINRERQKsLtLtPtRsDssEGFLQLPHQ |
| Q53EL6 | S457 | SIGNOR|ELM | PDCD4 H731 | GIISKQLRDLCPSRGRKRFVsEGDGGRLKPESY________ |
| Q53EL6 | S67 | SIGNOR|ELM | PDCD4 H731 | AssINEARINAKAKRRLRKNssRDsGRGDsVsDsGsDALRS |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5SSJ5 | S227 | Sugiyama | HP1BP3 | LKRELNRGVIKQVKGKGAsGsFVVVQKSRKTPQKSRNRKNR |
| Q5SW79 | S881 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | sstPssLALtsAsRIRERsEsLDPDssMDTtLILKDTEAVM |
| Q5TAX3 | S1384 | Sugiyama | TUT4 KIAA0191 ZCCHC11 | DAGHVRRECPEVKLARQRNssVAAAQLVRNLVNAQQVAGSA |
| Q5UE93 | T607 | SIGNOR | PIK3R6 C17orf38 | GAELSLCYQKALLSHRPREVtVSLRATGLILKAIPASDTEV |
| Q5VTB9 | T368 | Sugiyama | RNF220 C1orf164 | ENNNRFEEYEWCGQKRIRATtLLEGGFRGSGFIMCSGKENP |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q63ZY3 | S540 | Sugiyama | KANK2 ANKRD25 KIAA1518 MXRA3 SIP | NIsDNDSTENEAPEPRERVPsVAEAPQLRPAGTAAAKTSRQ |
| Q69YN4 | S1432 | Sugiyama | VIRMA KIAA1429 MSTP054 | CCGDDNGLMEVEGAHTSRTMsINAAELKQLLQSKEESPENL |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6P6C2 | S96 | Sugiyama | ALKBH5 ABH5 OFOXD1 | LQKEEEARKVKSGIRQMRLFsQDECAKIEARIDEVVSRAEK |
| Q6PJT7 | S327 | Sugiyama | ZC3H14 | KFNHDGEEEEEDDDYGSRtGsISsSVSVPAKPERRPsLPPS |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6U7Q0 | S224 | SIGNOR | ZNF322 ZNF322A ZNF388 ZNF489 | THTGERPYKCNKCEKSYRHRsAFIVHKRVHtGEKPYKCGAC |
| Q6U7Q0 | T150 | SIGNOR | ZNF322 ZNF322A ZNF388 ZNF489 | DICGKNFGQSSDLLVHQRSHtGEKPYLCSECDKCFSRSTNL |
| Q6U7Q0 | T234 | SIGNOR | ZNF322 ZNF322A ZNF388 ZNF489 | NKCEKSYRHRsAFIVHKRVHtGEKPYKCGACEKCFGQKSDL |
| Q6U7Q0 | T262 | SIGNOR | ZNF322 ZNF322A ZNF388 ZNF489 | GACEKCFGQKSDLIVHQRVHtGEKPYKCLECMRSFTRSANL |
| Q6ZWJ1 | S99 | SIGNOR | STXBP4 | IGVsFEEAKSIITGAKLRLEsAWEIAFIRQKSDNIQPENLS |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7L5N1 | S60 | SIGNOR | COPS6 CSN6 HVIP | SVALHPLVILNISDHWIRMRsQEGRPVQVIGALIGKQEGRN |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q7Z5H3 | S16 | SIGNOR | ARHGAP22 RHOGAP2 | _____MLSPKIRQARRARsKsLVMGEQSRSPGRMPCPHRLG |
| Q7Z5L9 | S457 | Sugiyama | IRF2BP2 | GSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVGGQ |
| Q7Z6J0 | S125 | GPS6 | SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2 | ANCSSKDLQSSQGGQQPRVQsWsPPVRGIPQLPCAKALYNY |
| Q7Z6J0 | S304 | SIGNOR|EPSD|PSP | SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2 | AQSSTAPKHSDTKKNTKKRHsFTSLTMANKssQAsQNRHsM |
| Q7Z6J0 | S800 | GPS6 | SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2 | PVTTAVAGAALAQDAFHRKAssLDSAVPIAPPPRQACSSLG |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86SQ0 | S417 | Sugiyama | PHLDB2 LL5B | SLRQAsGtPQPALRERKssIssISGRDDLMDYHRRQREERL |
| Q86SQ0 | S418 | Sugiyama | PHLDB2 LL5B | LRQAsGtPQPALRERKssIssISGRDDLMDYHRRQREERLR |
| Q86TX2 | T56 | Sugiyama | ACOT1 CTE1 | ASLRDEKGALFQAHARyRADtLGELDLERAPALGGSFAGLE |
| Q86V81 | T219 | SIGNOR | ALYREF ALY BEF THOC4 | GMTRNRGAGGFGGGGGTRRGtRGGARGRGRGAGRNSKQQLs |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q86YS7 | S197 | EPSD|PSP | C2CD5 CDP138 KIAA0528 | QWIDRIRTPRASNEARQRLIsLMsGELQRKIGLKVLEMRGN |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8N9L9 | S392 | SIGNOR | ACOT4 PTE2B PTEIB | ASLHRLLNKHVIWGGEPRAHsKAQEDAWKQILAFFCKHLGG |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBP7 | S487 | Sugiyama | PCSK9 NARC1 PSEC0052 | PTRMATAVARCAPDEELLsCssFSRSGKRRGERMEAQGGKL |
| Q8NCD3 | S486 | SIGNOR | HJURP FAKTS FLEG1 URLC9 | MYRGGPAsPGGLQGLETRRLsLPSSKAKAKsLSEAFENLGK |
| Q8TAP6 | S571 | Sugiyama | CEP76 C18orf9 | DQLSYLLSPALASYEFERTTsISAGNEEFQDAIRRAVPDGH |
| Q8TD19 | T333 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | REMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVWG |
| Q8TE77 | S37 | Sugiyama | SSH3 SSH3L | tPVGPWDQAVQRRSRLQRRQsFAVLRGAVLGLQDGGDNDDA |
| Q8WWI1 | T932 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | VtPRPFGsQtRGISsLPRsYtMDDAWKYNGDVEDIKRtPNN |
| Q8WX93 | S1118 | SIGNOR | PALLD KIAA0992 CGI-151 | RGRsPRsPsGHPHVRRPRsRsRDsGDENEPIQERFFRPHFL |
| Q8WX93 | S726 | Sugiyama | PALLD KIAA0992 CGI-151 | PAsPEPMSALASRsAPAMQssGsFNyARPKQFIAAQNLGPA |
| Q8WX93 | S728 | Sugiyama | PALLD KIAA0992 CGI-151 | sPEPMSALASRsAPAMQssGsFNyARPKQFIAAQNLGPAsG |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92597 | S367 | Sugiyama | NDRG1 CAP43 DRG1 RTP | SEGTRsRsHtsEGtRsRsHtsEGAHLDItPNsGAAGNsAGP |
| Q92614 | T228 | Sugiyama | MYO18A CD245 KIAA0216 MYSPDZ TIAF1 | PPVVPLPPPTLRELELQRRPtGDFGFsLRRTTMLDRGPEGQ |
| Q92766 | S1167 | Sugiyama | RREB1 FINB | AGTSKKRGRKRGMRSRPRANsGGVDLDssGEFASIEKMLAT |
| Q92879 | S28 | SIGNOR | CELF1 BRUNOL2 CUGBP CUGBP1 NAB50 | PDQPDLDAIKMFVGQVPRtWsEKDLRELFEQYGAVYEINVL |
| Q92900 | T151 | SIGNOR|PSP | UPF1 KIAA0221 RENT1 | PACVVYCNTSKKWFCNGRGNtSGSHIVNHLVRAKCKEVTLH |
| Q92934 | S118 | SIGNOR | BAD BBC6 BCL2L8 | RsAPPNLWAAQRYGRELRRMsDEFVDsFKKGLPRPKsAGtA |
| Q92934 | S75 | SIGNOR | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92934 | S99 | SIGNOR|ELM | BAD BBC6 BCL2L8 | GtEDDEGMGEEPsPFRGRsRsAPPNLWAAQRYGRELRRMsD |
| Q92945 | S193 | SIGNOR|EPSD|PSP|Sugiyama | KHSRP FUBP2 | DSGCKVQIsPDsGGLPERsVsLtGAPEsVQKAKMMLDDIVS |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93100 | S27 | Sugiyama | PHKB | LTAEVSWKVLERRARTKRsGsVyEPLKsINLPRPDNETLWD |
| Q96B36 | T246 | SIGNOR|ELM|EPSD | AKT1S1 PRAS40 | VLREAEDtQVFGDLPRPRLNtsDFQKLKRKY__________ |
| Q96F86 | S161 | SIGNOR|EPSD|PSP | EDC3 LSM16 YJDC YJEFN2 PP844 | YVDRHMEsLsQsKSFRRRHNsWssSSRHPNQAtPKKSGLKN |
| Q96FS4 | S55 | Sugiyama | SIPA1 SPA1 | PLTPHTFEPRPVRGPLLRsGsDAGEARPPtPAsPRARAHsH |
| Q96G46 | T240 | Sugiyama | DUS3L | KREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPRQENC |
| Q96HP0 | S1194 | SIGNOR | DOCK6 KIAA1395 | DTLPRLHDFAEGPGQRSRLAsMLDsDtEGEGDIAGTINPSV |
| Q96MH2 | T196 | Sugiyama | HEXIM2 L3 | GDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELVRD |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q96QB1 | S766 | SIGNOR | DLC1 ARHGAP7 KIAA1723 STARD12 | QSETSSAVSTPSPVTRTRsLsACNKRVGMYLEGFDPFNQST |
| Q96S44 | S250 | SIGNOR | TP53RK C20orf64 PRPK | KKARPVLKKLDEVRLRGRKRsMVG_________________ |
| Q99490 | S985 | SIGNOR | AGAP2 CENTG1 KIAA0167 | ICIECSGIHRNLGTHLSRVRsLDLDDWPRELTLVLTAIGND |
| Q99613 | S754 | Sugiyama | EIF3C EIF3S8 | REHVVAASKAMKMGDWKTCHsFIINEKMNGKVWDLFPEADK |
| Q99623 | S176 | PSP | PHB2 BAP REA | QRAQVsLLIRRELTERAKDFsLILDDVAITELSFSREYTAA |
| Q99623 | S91 | PSP | PHB2 BAP REA | RIPWFQYPIIYDIRARPRKIssPTGSKDLQMVNISLRVLSR |
| Q99683 | S83 | SIGNOR|ELM|EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | PGIGCPAATSSSSATRGRGSsVGGGSRRTTVAYVINEASQG |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q9BRS8 | S451 | SIGNOR | LARP6 | PWVRRRRQAEMGtQEKsPGtsPLLSRKMQTADGLPVGVLRL |
| Q9BVI0 | S291 | SIGNOR | PHF20 C20orf104 GLEA2 HCA58 NZF TZP | VDSNSQTLQPITLELRRRKIsKGCEVPLKRPRLDKNSSQEK |
| Q9BW19 | T159 | Sugiyama | KIFC1 HSET KNSL2 | LKGQLCDLNAELKRCRERtQtLDQENQQLQDQLRDAQQQVK |
| Q9BWT1 | T163 | SIGNOR | CDCA7 JPO1 | FRGRHPLPGSDSQSRRPRRRtFPGVASRRNPERRARPLTRS |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYW2 | S2080 | Sugiyama | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 | SRERDPDKQTQNKEKRKRRssLsPPssAYERGTKRPDDRYD |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZL6 | S197 | Sugiyama | PRKD2 PKD2 HSPC187 | HKRCAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPC |
| Q9BZL6 | T199 | Sugiyama | PRKD2 PKD2 HSPC187 | RCAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPCTA |
| Q9BZQ8 | S602 | SIGNOR | NIBAN1 C1orf24 FAM129A NIBAN GIG39 | sLtDLKPPtGsNQAsPARRAsAILPGVLGsEtLsNEVFQEs |
| Q9GZV1 | S99 | SIGNOR|EPSD|PSP | ANKRD2 ARPP | HGAQsAALQKVKGQERVRKTsLDLRREIIDVGGIQNLIELR |
| Q9H0B6 | S428 | Sugiyama | KLC2 | NKPIWMHAEEREESKDKRRDsAPyGEyGsWYKACKVDsPtV |
| Q9H0H5 | T249 | EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | PIEAVSTIETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPR |
| Q9H3H1 | S431 | Sugiyama | TRIT1 IPT MOD5 | AAHIKSKSHLNQLKKRRRLDsDAVNTIEsQsVsPDHNKEPK |
| Q9H3Q1 | S309 | Sugiyama | CDC42EP4 BORG4 CEP4 | AAPsPGsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPD |
| Q9H4A3 | T60 | SIGNOR|ELM | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GAAAADAVtGRtEEyRRRRHtMDKDSRGAAAtTtTTEHRFF |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H6Z4 | S126 | SIGNOR | RANBP3 | EDsDREDGNyCPPVKRERtssLtQFPPSQSEERSSGFRLKP |
| Q9H6Z4 | S57 | SIGNOR | RANBP3 | SGEEPRGEAEAPHHGTGHPEsAGEHALEPPAPAGASASTPP |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H788 | S316 | Sugiyama | SH2D4A PPP1R38 SH2A | NSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRAG |
| Q9HAU0 | S410 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | NRPNTGPLytEADRVIQRtNsMQQLEQWIKIQKGRGHEEET |
| Q9HBH7 | S102 | SIGNOR | BEX1 | MERIGEEVRQLMEKLREKQLsHSLRAVSTDPPHHDHHDEFC |
| Q9NP61 | S367 | Sugiyama | ARFGAP3 ARFGAP1 | DsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKDT |
| Q9NPC1 | T324 | SIGNOR | LTB4R2 BLT2R BLTR2 | LTRLFEGSGEARGGGRSREGtMELRTTPQLKVVGQGRGNGD |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NVN8 | S513 | Sugiyama | GNL3L | PNRHQMGWAKRNVDHRPKsNsMVDVCsVDRRSVLQRIMETD |
| Q9NWS0 | S173 | Sugiyama | PIH1D1 NOP17 | KYNLQLNPEWRMMKNRPFMGsIsQQNIRSEQRPRIQELGDL |
| Q9NZN5 | S1288 | Sugiyama | ARHGEF12 KIAA0382 LARG | GLTEKsVQEDWQHFPRyRtAsQGPQtDSVIQNSENIKAyHs |
| Q9P0N9 | S124 | SIGNOR | TBC1D7 TBC7 HSPC239 | QAEVYLRMYQLESGKLPRSPsFPLEPDDEVFLAIAKAMEEM |
| Q9UBK2 | S571 | SIGNOR | PPARGC1A LEM6 PGC1 PGC1A PPARGC1 | VSPPKSLFSQRPQRMRSRSRsFSRHRSCSRSPYSRSRSRSP |
| Q9UBP6 | S27 | SIGNOR|Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UH77 | S433 | SIGNOR | KLHL3 KIAA1129 | AYSYKTNEWFFVAPMNTRRSsVGVGVVEGKLYAVGGYDGAS |
| Q9UKJ3 | S890 | Sugiyama | GPATCH8 GPATC8 KIAA0553 | YSSSSDASSDQSCYSRQRSYsDDSYSDYSDRSRRHSKRSHD |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9ULD2 | S199 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | GKsQsFHtAGSLPPTGRRsGstsSLSySTWTSSHSDKTHAR |
| Q9ULL1 | S611 | Sugiyama | PLEKHG1 KIAA1209 | GQMESTETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTREL |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | S974 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPCsNVEsRLLPRYsHsGsssPDtKVKPEtPPRQsHsGsIs |
| Q9UQ35 | T977 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sNVEsRLLPRYsHsGsssPDtKVKPEtPPRQsHsGsIsPyP |
| Q9UQC2 | S159 | SIGNOR|ELM | GAB2 KIAA0571 | RssPAELssssQHLLRERKSsAPSHSSQPTLFTFEPPVSNH |
| Q9Y243 | T309 | Sugiyama | AKT3 PKBG | DFGLCKEGITDAATMKtFCGtPEyLAPEVLEDNDyGRAVDW |
| Q9Y261 | T156 | SIGNOR | FOXA2 HNF3B TCF3B | MYGQAGLSRARDPKTYRRSYtHAKPPYSYISLITMAIQQSP |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y2I7 | S307 | SIGNOR|ELM | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2I7 | S318 | EPSD | PIKFYVE KIAA0981 PIP5K3 | KsPARNRsAsItNLsLDRsGsPMVPSYEtsVsPQANRTYVR |
| Q9Y2T7 | S137 | SIGNOR | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y2V2 | S52 | SIGNOR|Sugiyama | CARHSP1 | sPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCKCFCR |
| Q9Y3C5 | T135 | SIGNOR | RNF11 CGI-123 | LPCMHIYHLDCIDDWLMRSFtCPSCMEPVDAALLSSYETN_ |
| Q9Y3M2 | S20 | EPSD|PSP | CBY1 ARB1 C22orf2 CBY PGEA1 HRIHFB2025 | _MPFFGNTFsPKKTPPRKsAsLsNLHsLDRSTREVELGLEY |
| Q9Y4H2 | S1149 | PSP | IRS2 | PHRGAKVIRADPQGGRRRHssEtFsstttVtPVsPsFAHNP |
| Q9Y4H2 | S306 | PSP | IRS2 | TILEAMKALKELFEFRPRsKsQssGssATHPISVPGARRHH |
| Q9Y4H2 | S365 | PSP | IRS2 | DsLAAtPPAAKCSSCRVRtAsEGDGGAAAGAAAAGARPVsV |
| Q9Y4H2 | S577 | PSP | IRS2 | RRVsGDAAQDLDRGLRKRtYsLtTPARQRPVPQPssAsLDE |
| Q9Y4I1 | T1650 | SIGNOR | MYO5A MYH12 | LEHETIQGVSGVKPTGLRKRtssIADEGtYTLDSILRQLNS |
| Q9Y4P1 | S34 | SIGNOR | ATG4B APG4B AUTL1 KIAA0943 | AEFEDFPETSEPVWILGRKYsIFtEKDEILSDVASRLWFTY |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y6D5 | S277 | Sugiyama | ARFGEF2 ARFGEP2 BIG2 | RSDSGKVSTENGDAPRERGssLsGtDDGAQEVVKDILEDVV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.592056e-09 | 8.586 | 1 | 1 |
| Chromatin organization | R-HSA-4839726 | 1.154912e-08 | 7.937 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.103526e-08 | 7.957 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.645950e-08 | 7.333 | 1 | 0 |
| Signal Transduction | R-HSA-162582 | 2.571574e-07 | 6.590 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.510148e-07 | 6.346 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.243858e-07 | 6.034 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.807967e-07 | 6.055 | 1 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.256466e-07 | 6.034 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.551710e-07 | 6.068 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.302823e-06 | 5.638 | 1 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.788401e-06 | 5.555 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.169511e-06 | 5.499 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.670229e-06 | 5.435 | 1 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.696719e-06 | 5.328 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.277890e-06 | 5.138 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.365807e-06 | 5.077 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.794065e-06 | 5.056 | 1 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.010998e-05 | 4.995 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.839365e-06 | 5.007 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.155560e-05 | 4.937 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.320300e-05 | 4.879 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.300313e-05 | 4.886 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.392936e-05 | 4.856 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.522975e-05 | 4.817 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.777901e-05 | 4.750 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.784656e-05 | 4.555 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.739203e-05 | 4.562 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.221838e-05 | 4.492 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.141541e-05 | 4.503 | 1 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.408502e-05 | 4.356 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.521147e-05 | 4.345 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.743706e-05 | 4.241 | 1 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.888118e-05 | 4.162 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.840352e-05 | 4.106 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.153549e-05 | 4.038 | 1 | 0 |
| Meiosis | R-HSA-1500620 | 9.596332e-05 | 4.018 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.252542e-05 | 4.034 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.039818e-04 | 3.983 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.114766e-04 | 3.953 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.312022e-04 | 3.882 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.339912e-04 | 3.873 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.500129e-04 | 3.824 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.909791e-04 | 3.719 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.897576e-04 | 3.722 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.829995e-04 | 3.738 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.928565e-04 | 3.715 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.942328e-04 | 3.712 | 1 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.097223e-04 | 3.678 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.343013e-04 | 3.630 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.563689e-04 | 3.591 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.718210e-04 | 3.566 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.053872e-04 | 3.515 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.395688e-04 | 3.469 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.384856e-04 | 3.470 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.410705e-04 | 3.467 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.395688e-04 | 3.469 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.554658e-04 | 3.449 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.657942e-04 | 3.437 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.771753e-04 | 3.423 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.127574e-04 | 3.384 | 1 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.145470e-04 | 3.289 | 1 | 1 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.511528e-04 | 3.259 | 1 | 1 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.472640e-04 | 3.262 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.567807e-04 | 3.254 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.460463e-04 | 3.190 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.529583e-04 | 3.185 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.643851e-04 | 3.117 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.041223e-04 | 3.095 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.301600e-04 | 3.081 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.927726e-04 | 3.049 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.815138e-04 | 3.008 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.223170e-04 | 3.035 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.508654e-04 | 3.022 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.857969e-04 | 3.006 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.096319e-03 | 2.960 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.101133e-03 | 2.958 | 1 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.169304e-03 | 2.932 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.294897e-03 | 2.888 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.366723e-03 | 2.864 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.404329e-03 | 2.853 | 1 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.415769e-03 | 2.849 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.478985e-03 | 2.830 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.478985e-03 | 2.830 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.640748e-03 | 2.785 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.684314e-03 | 2.774 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.773225e-03 | 2.751 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.783779e-03 | 2.749 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.805740e-03 | 2.743 | 1 | 1 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.852276e-03 | 2.732 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.067236e-03 | 2.685 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.067236e-03 | 2.685 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.067236e-03 | 2.685 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.067236e-03 | 2.685 | 1 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.099523e-03 | 2.678 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.376768e-03 | 2.624 | 1 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.511517e-03 | 2.600 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 2.681051e-03 | 2.572 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.806004e-03 | 2.552 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.029217e-03 | 2.519 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.272287e-03 | 2.485 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.282784e-03 | 2.484 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.186391e-03 | 2.497 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.454670e-03 | 2.462 | 1 | 0 |
| RET signaling | R-HSA-8853659 | 3.879468e-03 | 2.411 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.233121e-03 | 2.373 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.344848e-03 | 2.362 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.344848e-03 | 2.362 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.553278e-03 | 2.342 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.637668e-03 | 2.334 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 4.717612e-03 | 2.326 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.717612e-03 | 2.326 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.174061e-03 | 2.286 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.174061e-03 | 2.286 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.335648e-03 | 2.273 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.618533e-03 | 2.250 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.925644e-03 | 2.227 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.696313e-03 | 2.244 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.943003e-03 | 2.226 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.943003e-03 | 2.226 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.949935e-03 | 2.225 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.982279e-03 | 2.223 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.021802e-03 | 2.220 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.125140e-03 | 2.213 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.166792e-03 | 2.210 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.762117e-03 | 2.170 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.803214e-03 | 2.167 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 7.761773e-03 | 2.110 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.452055e-03 | 2.128 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.955051e-03 | 2.099 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.103290e-03 | 2.091 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.288372e-03 | 2.082 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 9.623793e-03 | 2.017 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.017388e-02 | 1.993 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.022562e-02 | 1.990 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.384935e-03 | 2.028 | 1 | 1 |
| Calmodulin induced events | R-HSA-111933 | 9.384935e-03 | 2.028 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.749732e-03 | 2.011 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.384935e-03 | 2.028 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.028956e-02 | 1.988 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.079275e-02 | 1.967 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.085822e-02 | 1.964 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.089892e-02 | 1.963 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.089892e-02 | 1.963 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.089892e-02 | 1.963 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.093977e-02 | 1.961 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.110637e-02 | 1.954 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.115683e-02 | 1.952 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.115683e-02 | 1.952 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.117121e-02 | 1.952 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.236866e-02 | 1.908 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.163396e-02 | 1.934 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.275478e-02 | 1.894 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.273302e-02 | 1.895 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.164674e-02 | 1.934 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.301514e-02 | 1.886 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.338928e-02 | 1.873 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.410438e-02 | 1.851 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.455652e-02 | 1.837 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.525666e-02 | 1.817 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.552199e-02 | 1.809 | 1 | 1 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.810991e-02 | 1.742 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.810991e-02 | 1.742 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.810991e-02 | 1.742 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.810991e-02 | 1.742 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.661029e-02 | 1.780 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.661029e-02 | 1.780 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.791265e-02 | 1.747 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.715104e-02 | 1.766 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.717211e-02 | 1.765 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.701129e-02 | 1.769 | 1 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.635406e-02 | 1.786 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.810991e-02 | 1.742 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.723735e-02 | 1.764 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.744799e-02 | 1.758 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.844053e-02 | 1.734 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.963560e-02 | 1.707 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.964620e-02 | 1.707 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.964620e-02 | 1.707 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.988764e-02 | 1.701 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.026257e-02 | 1.693 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.073378e-02 | 1.683 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.114279e-02 | 1.675 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.199031e-02 | 1.658 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.234394e-02 | 1.651 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.299222e-02 | 1.638 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.311089e-02 | 1.636 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.387136e-02 | 1.622 | 1 | 1 |
| Cardiogenesis | R-HSA-9733709 | 2.489423e-02 | 1.604 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.502170e-02 | 1.602 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.601920e-02 | 1.585 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.384453e-02 | 1.623 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.610704e-02 | 1.583 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.647917e-02 | 1.577 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.675199e-02 | 1.573 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.745393e-02 | 1.561 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.747324e-02 | 1.561 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.772661e-02 | 1.557 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.772661e-02 | 1.557 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.772661e-02 | 1.557 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.772661e-02 | 1.557 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.772661e-02 | 1.557 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.791869e-02 | 1.554 | 1 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.791869e-02 | 1.554 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.804375e-02 | 1.552 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.872417e-02 | 1.542 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.949960e-02 | 1.530 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.294503e-02 | 1.482 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.294503e-02 | 1.482 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.294503e-02 | 1.482 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.294503e-02 | 1.482 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.294503e-02 | 1.482 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 3.525032e-02 | 1.453 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.337639e-02 | 1.477 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.380613e-02 | 1.471 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.297593e-02 | 1.482 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.151126e-02 | 1.502 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.419053e-02 | 1.466 | 1 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.525032e-02 | 1.453 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.314540e-02 | 1.480 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.525293e-02 | 1.453 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.862390e-02 | 1.413 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.929286e-02 | 1.406 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.988347e-02 | 1.399 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.011170e-02 | 1.397 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.018975e-02 | 1.396 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.054719e-02 | 1.392 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.106771e-02 | 1.386 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.248666e-02 | 1.372 | 1 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.258878e-02 | 1.371 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.284551e-02 | 1.368 | 1 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.301183e-02 | 1.366 | 1 | 1 |
| Programmed Cell Death | R-HSA-5357801 | 4.425401e-02 | 1.354 | 1 | 0 |
| Muscle contraction | R-HSA-397014 | 4.626215e-02 | 1.335 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.408551e-02 | 1.267 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.462461e-02 | 1.263 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.462461e-02 | 1.263 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.693130e-02 | 1.329 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.693130e-02 | 1.329 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.319007e-02 | 1.274 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.106162e-02 | 1.292 | 1 | 1 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.915852e-02 | 1.308 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.835305e-02 | 1.316 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.835305e-02 | 1.316 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.001427e-02 | 1.301 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.138261e-02 | 1.289 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.693130e-02 | 1.329 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.693130e-02 | 1.329 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.319007e-02 | 1.274 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.408551e-02 | 1.267 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.821071e-02 | 1.317 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.228393e-02 | 1.282 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.732697e-02 | 1.325 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.004881e-02 | 1.301 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.471655e-02 | 1.262 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.471655e-02 | 1.262 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.471655e-02 | 1.262 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.471655e-02 | 1.262 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.471655e-02 | 1.262 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.476522e-02 | 1.261 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.622855e-02 | 1.250 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.631122e-02 | 1.249 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.631122e-02 | 1.249 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.773312e-02 | 1.239 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.793109e-02 | 1.237 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.819674e-02 | 1.235 | 1 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.953558e-02 | 1.225 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.767800e-02 | 1.170 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.330028e-02 | 1.199 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.330028e-02 | 1.199 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.647116e-02 | 1.177 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.677510e-02 | 1.175 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.677510e-02 | 1.175 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.677510e-02 | 1.175 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.677510e-02 | 1.175 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.677510e-02 | 1.175 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.677510e-02 | 1.175 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.903589e-02 | 1.161 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.330028e-02 | 1.199 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.685565e-02 | 1.175 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.388046e-02 | 1.195 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.191344e-02 | 1.143 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.338089e-02 | 1.198 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.067600e-02 | 1.151 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.438175e-02 | 1.191 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.551292e-02 | 1.184 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.551292e-02 | 1.184 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.331138e-02 | 1.199 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.191344e-02 | 1.143 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.175069e-02 | 1.209 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.538503e-02 | 1.185 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.191344e-02 | 1.143 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.256061e-02 | 1.139 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.256061e-02 | 1.139 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.256061e-02 | 1.139 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.274243e-02 | 1.138 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.415468e-02 | 1.130 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.577906e-02 | 1.120 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.577906e-02 | 1.120 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.577906e-02 | 1.120 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.637492e-02 | 1.117 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.685696e-02 | 1.114 | 1 | 1 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.768682e-02 | 1.110 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.795918e-02 | 1.108 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.795918e-02 | 1.108 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.812275e-02 | 1.107 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.830982e-02 | 1.106 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.830982e-02 | 1.106 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.830982e-02 | 1.106 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.830982e-02 | 1.106 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.830982e-02 | 1.106 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.830982e-02 | 1.106 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.830982e-02 | 1.106 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.877011e-02 | 1.104 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.208570e-02 | 1.086 | 1 | 1 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.521979e-02 | 1.069 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.521979e-02 | 1.069 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.521979e-02 | 1.069 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.521979e-02 | 1.069 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.688457e-02 | 1.061 | 1 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.757298e-02 | 1.058 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.049838e-01 | 0.979 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.049838e-01 | 0.979 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.049838e-01 | 0.979 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.049838e-01 | 0.979 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.049838e-01 | 0.979 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 9.164459e-02 | 1.038 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 9.164459e-02 | 1.038 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.098014e-01 | 0.959 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.097893e-02 | 1.041 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.097893e-02 | 1.041 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.904511e-02 | 1.004 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.787042e-02 | 1.009 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 9.134369e-02 | 1.039 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.628347e-02 | 1.016 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.138684e-02 | 1.039 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.176287e-02 | 1.037 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.098014e-01 | 0.959 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.232145e-02 | 1.035 | 1 | 1 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.164459e-02 | 1.038 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.904511e-02 | 1.004 | 1 | 1 |
| Frs2-mediated activation | R-HSA-170968 | 9.505371e-02 | 1.022 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.070241e-01 | 0.971 | 1 | 1 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.095574e-01 | 0.960 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.326336e-02 | 1.030 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.048596e-01 | 0.979 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.403879e-02 | 1.027 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.047836e-01 | 0.980 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.776632e-02 | 1.010 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.134369e-02 | 1.039 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.047836e-01 | 0.980 | 1 | 1 |
| Kinesins | R-HSA-983189 | 1.062451e-01 | 0.974 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.047007e-01 | 0.980 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.035806e-01 | 0.985 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.098014e-01 | 0.959 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.097893e-02 | 1.041 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.025912e-02 | 1.045 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.098014e-01 | 0.959 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.099769e-01 | 0.959 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 1.099769e-01 | 0.959 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.099769e-01 | 0.959 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.103462e-01 | 0.957 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.115211e-01 | 0.953 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.134596e-01 | 0.945 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 1.134596e-01 | 0.945 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 1.134596e-01 | 0.945 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.134596e-01 | 0.945 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.136568e-01 | 0.944 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.136568e-01 | 0.944 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.136568e-01 | 0.944 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.136568e-01 | 0.944 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.153977e-01 | 0.938 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.154512e-01 | 0.938 | 1 | 1 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.170714e-01 | 0.932 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.170714e-01 | 0.932 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.206538e-01 | 0.918 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.213963e-01 | 0.916 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.216938e-01 | 0.915 | 1 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.227425e-01 | 0.911 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.244161e-01 | 0.905 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.246667e-01 | 0.904 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.246667e-01 | 0.904 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.246667e-01 | 0.904 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.258858e-01 | 0.900 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.263580e-01 | 0.898 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.268211e-01 | 0.897 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.313784e-01 | 0.881 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.313784e-01 | 0.881 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.313784e-01 | 0.881 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.313784e-01 | 0.881 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.572560e-01 | 0.803 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.572560e-01 | 0.803 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.354438e-01 | 0.868 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.354438e-01 | 0.868 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.684994e-01 | 0.773 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.684994e-01 | 0.773 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.684994e-01 | 0.773 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.684994e-01 | 0.773 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.684994e-01 | 0.773 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.377457e-01 | 0.861 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.377457e-01 | 0.861 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.377457e-01 | 0.861 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.377457e-01 | 0.861 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.548448e-01 | 0.810 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.548448e-01 | 0.810 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.519990e-01 | 0.818 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.301107e-01 | 0.886 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.301107e-01 | 0.886 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.328043e-01 | 0.877 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.593252e-01 | 0.798 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.578096e-01 | 0.802 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.578096e-01 | 0.802 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.681313e-01 | 0.774 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.343951e-01 | 0.872 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.697255e-01 | 0.770 | 1 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.643564e-01 | 0.784 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.636760e-01 | 0.786 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.301107e-01 | 0.886 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.636760e-01 | 0.786 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.659924e-01 | 0.780 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.445584e-01 | 0.840 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.445584e-01 | 0.840 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.445584e-01 | 0.840 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.548448e-01 | 0.810 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.481439e-01 | 0.829 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.481439e-01 | 0.829 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.334558e-01 | 0.875 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.636760e-01 | 0.786 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.704732e-01 | 0.768 | 1 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.353403e-01 | 0.869 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.343951e-01 | 0.872 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.636760e-01 | 0.786 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.636760e-01 | 0.786 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.548448e-01 | 0.810 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.467546e-01 | 0.833 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.547941e-01 | 0.810 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.619346e-01 | 0.791 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.519990e-01 | 0.818 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.622849e-01 | 0.790 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.582840e-01 | 0.801 | 1 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.681313e-01 | 0.774 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.715705e-01 | 0.766 | 1 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.723983e-01 | 0.763 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.727250e-01 | 0.763 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.734929e-01 | 0.761 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.769701e-01 | 0.752 | 1 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.794826e-01 | 0.746 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.799613e-01 | 0.745 | 1 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.842358e-01 | 0.735 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.847044e-01 | 0.734 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.848224e-01 | 0.733 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.881567e-01 | 0.725 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.881567e-01 | 0.725 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.881567e-01 | 0.725 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.882825e-01 | 0.725 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.892784e-01 | 0.723 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.894125e-01 | 0.723 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.894125e-01 | 0.723 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.455031e-01 | 0.610 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.455031e-01 | 0.610 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.455031e-01 | 0.610 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.455031e-01 | 0.610 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.455031e-01 | 0.610 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.455031e-01 | 0.610 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.455031e-01 | 0.610 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.074779e-01 | 0.683 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.074779e-01 | 0.683 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.074779e-01 | 0.683 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.074779e-01 | 0.683 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.074779e-01 | 0.683 | 1 | 1 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.074779e-01 | 0.683 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.074779e-01 | 0.683 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.074779e-01 | 0.683 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.446392e-01 | 0.463 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.446392e-01 | 0.463 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.446392e-01 | 0.463 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.446392e-01 | 0.463 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.446392e-01 | 0.463 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.446392e-01 | 0.463 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.446392e-01 | 0.463 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.446392e-01 | 0.463 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.446392e-01 | 0.463 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.446392e-01 | 0.463 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.446392e-01 | 0.463 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.446392e-01 | 0.463 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.446392e-01 | 0.463 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.446392e-01 | 0.463 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.446392e-01 | 0.463 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.446392e-01 | 0.463 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.446392e-01 | 0.463 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.446392e-01 | 0.463 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.446392e-01 | 0.463 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.446392e-01 | 0.463 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.590543e-01 | 0.587 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.590543e-01 | 0.587 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.590543e-01 | 0.587 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.590543e-01 | 0.587 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.035811e-01 | 0.691 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.035811e-01 | 0.691 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.035811e-01 | 0.691 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.035811e-01 | 0.691 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.035811e-01 | 0.691 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.035811e-01 | 0.691 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.911919e-01 | 0.719 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.911919e-01 | 0.719 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.911919e-01 | 0.719 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.911919e-01 | 0.719 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.911919e-01 | 0.719 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.401405e-01 | 0.620 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.401405e-01 | 0.620 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.401405e-01 | 0.620 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.107628e-01 | 0.508 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.107628e-01 | 0.508 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.107628e-01 | 0.508 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.107628e-01 | 0.508 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.107628e-01 | 0.508 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.307544e-01 | 0.366 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.307544e-01 | 0.366 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.307544e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.307544e-01 | 0.366 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.307544e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.307544e-01 | 0.366 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.307544e-01 | 0.366 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.307544e-01 | 0.366 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.307544e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.307544e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.307544e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.307544e-01 | 0.366 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.307544e-01 | 0.366 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.307544e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.307544e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.307544e-01 | 0.366 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.307544e-01 | 0.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.307544e-01 | 0.366 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.200274e-01 | 0.658 | 1 | 1 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.200274e-01 | 0.658 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.200274e-01 | 0.658 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.200274e-01 | 0.658 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.776655e-01 | 0.556 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.776655e-01 | 0.556 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.499138e-01 | 0.602 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.616791e-01 | 0.442 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.059783e-01 | 0.686 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.156896e-01 | 0.501 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.156896e-01 | 0.501 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.156896e-01 | 0.501 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.156896e-01 | 0.501 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.805869e-01 | 0.552 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.805869e-01 | 0.552 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.805869e-01 | 0.552 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.520672e-01 | 0.598 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.280733e-01 | 0.642 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.074356e-01 | 0.683 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.074356e-01 | 0.683 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.508802e-01 | 0.601 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.784712e-01 | 0.555 | 1 | 1 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.117919e-01 | 0.506 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.117919e-01 | 0.506 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.537974e-01 | 0.451 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.537974e-01 | 0.451 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.111189e-01 | 0.386 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.111189e-01 | 0.386 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.111189e-01 | 0.386 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.111189e-01 | 0.386 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.111189e-01 | 0.386 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.111189e-01 | 0.386 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 4.111189e-01 | 0.386 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.111189e-01 | 0.386 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.055583e-01 | 0.296 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.055583e-01 | 0.296 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.055583e-01 | 0.296 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.055583e-01 | 0.296 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 5.055583e-01 | 0.296 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 5.055583e-01 | 0.296 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.055583e-01 | 0.296 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.055583e-01 | 0.296 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.056559e-01 | 0.687 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.056559e-01 | 0.687 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.480211e-01 | 0.606 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.480211e-01 | 0.606 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.480211e-01 | 0.606 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.742866e-01 | 0.562 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.053891e-01 | 0.515 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.225868e-01 | 0.653 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.225868e-01 | 0.653 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.225868e-01 | 0.653 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.432881e-01 | 0.464 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.691673e-01 | 0.570 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.981795e-01 | 0.526 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.916261e-01 | 0.407 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.916261e-01 | 0.407 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.916261e-01 | 0.407 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.916261e-01 | 0.407 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.156725e-01 | 0.666 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.907719e-01 | 0.536 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.224461e-01 | 0.492 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.224461e-01 | 0.492 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.748514e-01 | 0.426 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.748514e-01 | 0.426 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.585914e-01 | 0.339 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.585914e-01 | 0.339 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.585914e-01 | 0.339 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.465121e-01 | 0.608 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.127505e-01 | 0.505 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.469756e-01 | 0.460 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.469756e-01 | 0.460 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.288653e-01 | 0.368 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.288653e-01 | 0.368 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.149683e-01 | 0.668 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.350192e-01 | 0.475 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.377854e-01 | 0.624 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.062771e-01 | 0.391 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.716603e-01 | 0.430 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.963969e-01 | 0.402 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.151295e-01 | 0.382 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.373802e-01 | 0.359 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.373802e-01 | 0.359 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.373802e-01 | 0.359 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.652550e-01 | 0.332 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 5.037601e-01 | 0.298 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 5.037601e-01 | 0.298 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 5.705360e-01 | 0.244 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.705360e-01 | 0.244 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.705360e-01 | 0.244 | 1 | 1 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.705360e-01 | 0.244 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.705360e-01 | 0.244 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.705360e-01 | 0.244 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.705360e-01 | 0.244 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.865639e-01 | 0.413 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.210871e-01 | 0.376 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.210871e-01 | 0.376 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.639761e-01 | 0.439 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.853723e-01 | 0.414 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.005822e-01 | 0.301 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.005822e-01 | 0.301 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.005822e-01 | 0.301 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.005822e-01 | 0.301 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.005822e-01 | 0.301 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.699647e-01 | 0.328 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 4.979842e-01 | 0.303 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 4.979842e-01 | 0.303 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.464107e-01 | 0.262 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.875821e-01 | 0.412 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.875821e-01 | 0.412 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.527077e-01 | 0.344 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.939866e-01 | 0.306 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.346776e-01 | 0.272 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.923655e-01 | 0.308 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.406593e-01 | 0.356 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.909113e-01 | 0.309 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.272194e-01 | 0.278 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.218295e-01 | 0.282 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.356921e-01 | 0.271 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.356921e-01 | 0.271 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.408355e-01 | 0.267 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.472331e-01 | 0.262 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.472331e-01 | 0.262 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.555995e-01 | 0.255 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.674106e-01 | 0.246 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.674106e-01 | 0.246 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.674106e-01 | 0.246 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.674106e-01 | 0.246 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.674106e-01 | 0.246 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.452318e-01 | 0.263 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.596161e-01 | 0.252 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.472331e-01 | 0.262 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.191138e-01 | 0.496 | 1 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.923655e-01 | 0.308 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.923655e-01 | 0.308 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.285767e-01 | 0.368 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.554641e-01 | 0.255 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.554641e-01 | 0.255 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.954363e-01 | 0.530 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.253665e-01 | 0.371 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.347454e-01 | 0.475 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.979842e-01 | 0.303 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.218295e-01 | 0.282 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.263399e-01 | 0.645 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.432881e-01 | 0.464 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.472331e-01 | 0.262 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.702965e-01 | 0.328 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.447288e-01 | 0.463 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.512040e-01 | 0.259 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.037601e-01 | 0.298 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.386987e-01 | 0.269 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.059783e-01 | 0.686 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.442675e-01 | 0.612 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.264888e-01 | 0.645 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.652550e-01 | 0.332 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.005822e-01 | 0.301 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.693176e-01 | 0.329 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.169415e-01 | 0.664 | 1 | 1 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.029579e-01 | 0.519 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.354655e-01 | 0.474 | 1 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.401405e-01 | 0.620 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.776655e-01 | 0.556 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.263399e-01 | 0.645 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.585914e-01 | 0.339 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.151295e-01 | 0.382 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.464107e-01 | 0.262 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.190312e-01 | 0.378 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.423373e-01 | 0.466 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.432881e-01 | 0.464 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.113775e-01 | 0.386 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.113775e-01 | 0.386 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.401405e-01 | 0.620 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.107628e-01 | 0.508 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.776655e-01 | 0.556 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 3.156896e-01 | 0.501 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.111189e-01 | 0.386 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.254046e-01 | 0.647 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.456383e-01 | 0.351 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.979842e-01 | 0.303 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.464107e-01 | 0.262 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.464107e-01 | 0.262 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.694777e-01 | 0.328 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.144362e-01 | 0.383 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.524820e-01 | 0.453 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.161411e-01 | 0.500 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.512040e-01 | 0.259 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.911919e-01 | 0.719 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.401405e-01 | 0.620 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.401405e-01 | 0.620 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.705360e-01 | 0.244 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.005822e-01 | 0.301 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.452192e-01 | 0.610 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.406593e-01 | 0.356 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.536469e-01 | 0.343 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.981795e-01 | 0.526 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.916261e-01 | 0.407 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.579218e-01 | 0.589 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.521913e-01 | 0.598 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.062771e-01 | 0.391 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 3.716603e-01 | 0.430 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.293684e-01 | 0.482 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.963969e-01 | 0.402 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.187399e-01 | 0.660 | 1 | 1 |
| Potassium Channels | R-HSA-1296071 | 2.565691e-01 | 0.591 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.665023e-01 | 0.574 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.293684e-01 | 0.482 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.659547e-01 | 0.437 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.458509e-01 | 0.263 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.907719e-01 | 0.536 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.484547e-01 | 0.458 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.546760e-01 | 0.594 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.560211e-01 | 0.449 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.659547e-01 | 0.437 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.881589e-01 | 0.311 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.401405e-01 | 0.620 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.616791e-01 | 0.442 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.070999e-01 | 0.684 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 3.537974e-01 | 0.451 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.742866e-01 | 0.562 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.585914e-01 | 0.339 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.585914e-01 | 0.339 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.585914e-01 | 0.339 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.127505e-01 | 0.505 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.127505e-01 | 0.505 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.350192e-01 | 0.475 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 5.037601e-01 | 0.298 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.285767e-01 | 0.368 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.702965e-01 | 0.328 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.931401e-01 | 0.714 | 1 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.406917e-01 | 0.468 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.702083e-01 | 0.328 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.550544e-01 | 0.593 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.358825e-01 | 0.361 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.635393e-01 | 0.249 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.350192e-01 | 0.475 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.253665e-01 | 0.371 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.199089e-01 | 0.495 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.432881e-01 | 0.464 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.861640e-01 | 0.313 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.075784e-01 | 0.390 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.708820e-01 | 0.567 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.499138e-01 | 0.602 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.274166e-01 | 0.643 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.916261e-01 | 0.407 | 1 | 1 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.140587e-01 | 0.503 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.447288e-01 | 0.463 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.800965e-01 | 0.420 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.074779e-01 | 0.683 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.805869e-01 | 0.552 | 1 | 1 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.748514e-01 | 0.426 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.127505e-01 | 0.505 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.005822e-01 | 0.301 | 1 | 1 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.464107e-01 | 0.262 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.632488e-01 | 0.440 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.854364e-01 | 0.544 | 1 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.062771e-01 | 0.391 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.742866e-01 | 0.562 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.350192e-01 | 0.475 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.142001e-01 | 0.289 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.674106e-01 | 0.246 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.633338e-01 | 0.249 | 1 | 1 |
| Adaptive Immune System | R-HSA-1280218 | 5.549917e-01 | 0.256 | 1 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.676410e-01 | 0.572 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.198604e-01 | 0.658 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 4.111189e-01 | 0.386 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.748514e-01 | 0.426 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.127505e-01 | 0.505 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.037601e-01 | 0.298 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.158623e-01 | 0.287 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.169445e-01 | 0.380 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.967430e-01 | 0.304 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.423373e-01 | 0.466 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.674326e-01 | 0.246 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.699647e-01 | 0.328 | 1 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.169415e-01 | 0.664 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.046093e-01 | 0.689 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.153268e-01 | 0.667 | 1 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.455031e-01 | 0.610 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.455031e-01 | 0.610 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.035811e-01 | 0.691 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.401405e-01 | 0.620 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.107628e-01 | 0.508 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.307544e-01 | 0.366 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.307544e-01 | 0.366 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.307544e-01 | 0.366 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.263399e-01 | 0.645 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.156896e-01 | 0.501 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.156896e-01 | 0.501 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.520672e-01 | 0.598 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.274166e-01 | 0.643 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.117919e-01 | 0.506 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.055583e-01 | 0.296 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.742866e-01 | 0.562 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.432881e-01 | 0.464 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.585914e-01 | 0.339 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.858558e-01 | 0.544 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.037601e-01 | 0.298 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.705360e-01 | 0.244 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.705360e-01 | 0.244 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.693176e-01 | 0.329 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.958306e-01 | 0.305 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.939866e-01 | 0.306 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.674106e-01 | 0.246 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.144362e-01 | 0.383 | 1 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.423312e-01 | 0.266 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.423312e-01 | 0.266 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.963969e-01 | 0.402 | 1 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 3.698067e-01 | 0.432 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.655933e-01 | 0.437 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.635393e-01 | 0.249 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.911919e-01 | 0.719 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.138538e-01 | 0.503 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.210871e-01 | 0.376 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.895868e-01 | 0.310 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.401405e-01 | 0.620 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.464107e-01 | 0.262 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.674106e-01 | 0.246 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.326625e-01 | 0.478 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.127505e-01 | 0.505 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.218295e-01 | 0.282 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.590543e-01 | 0.587 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.401405e-01 | 0.620 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.107628e-01 | 0.508 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.111189e-01 | 0.386 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.916261e-01 | 0.407 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.916261e-01 | 0.407 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.916261e-01 | 0.407 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.748514e-01 | 0.426 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.601387e-01 | 0.444 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 2.713620e-01 | 0.566 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.870301e-01 | 0.542 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.705360e-01 | 0.244 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.679969e-01 | 0.330 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.939866e-01 | 0.306 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.176320e-01 | 0.286 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.062316e-01 | 0.296 | 1 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.412537e-01 | 0.355 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 4.288653e-01 | 0.368 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.327720e-01 | 0.633 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.693176e-01 | 0.329 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.635393e-01 | 0.249 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.151912e-01 | 0.501 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.916261e-01 | 0.407 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.515641e-01 | 0.345 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.524820e-01 | 0.453 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.345991e-01 | 0.362 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.083475e-01 | 0.511 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.224461e-01 | 0.492 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.470145e-01 | 0.262 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.694389e-01 | 0.570 | 1 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.446392e-01 | 0.463 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.307544e-01 | 0.366 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.200274e-01 | 0.658 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.776655e-01 | 0.556 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.156896e-01 | 0.501 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.055583e-01 | 0.296 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.055583e-01 | 0.296 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 4.585914e-01 | 0.339 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.652550e-01 | 0.332 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.037601e-01 | 0.298 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.705360e-01 | 0.244 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.705360e-01 | 0.244 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.979842e-01 | 0.303 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.464107e-01 | 0.262 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.702419e-01 | 0.328 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.472331e-01 | 0.262 | 1 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.674106e-01 | 0.246 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.674106e-01 | 0.246 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.355213e-01 | 0.628 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.218295e-01 | 0.282 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.520672e-01 | 0.598 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 4.151295e-01 | 0.382 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.127505e-01 | 0.505 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.056559e-01 | 0.687 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.320418e-01 | 0.634 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.053891e-01 | 0.515 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.055583e-01 | 0.296 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.037601e-01 | 0.298 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.176320e-01 | 0.286 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.005822e-01 | 0.301 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.005822e-01 | 0.301 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.307544e-01 | 0.366 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.616791e-01 | 0.442 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.111189e-01 | 0.386 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.055583e-01 | 0.296 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.055583e-01 | 0.296 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.326625e-01 | 0.478 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.585914e-01 | 0.339 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.585914e-01 | 0.339 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.705360e-01 | 0.244 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.674106e-01 | 0.246 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.962625e-01 | 0.707 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.007327e-01 | 0.397 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.742866e-01 | 0.562 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.693176e-01 | 0.329 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 4.373802e-01 | 0.359 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.805869e-01 | 0.552 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.354622e-01 | 0.628 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.062771e-01 | 0.391 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.705053e-01 | 0.568 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.739592e-01 | 0.324 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.528355e-01 | 0.452 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.046450e-01 | 0.393 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.464107e-01 | 0.262 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.719716e-01 | 0.243 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.719716e-01 | 0.243 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.719716e-01 | 0.243 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.719716e-01 | 0.243 | 1 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.719716e-01 | 0.243 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.734584e-01 | 0.241 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.804580e-01 | 0.236 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.830401e-01 | 0.234 | 1 | 1 |
| Syndecan interactions | R-HSA-3000170 | 5.830401e-01 | 0.234 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.850969e-01 | 0.233 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.856924e-01 | 0.232 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.864252e-01 | 0.232 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.864252e-01 | 0.232 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.864252e-01 | 0.232 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.864252e-01 | 0.232 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.864252e-01 | 0.232 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.933385e-01 | 0.227 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.953527e-01 | 0.225 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.959859e-01 | 0.225 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.976501e-01 | 0.224 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.976501e-01 | 0.224 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.986862e-01 | 0.223 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.986862e-01 | 0.223 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.986862e-01 | 0.223 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.986862e-01 | 0.223 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.986862e-01 | 0.223 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.006899e-01 | 0.221 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.006899e-01 | 0.221 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.046937e-01 | 0.218 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.071397e-01 | 0.217 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.072510e-01 | 0.217 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.072510e-01 | 0.217 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.083353e-01 | 0.216 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.083353e-01 | 0.216 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.083353e-01 | 0.216 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.094743e-01 | 0.215 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.094743e-01 | 0.215 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.094743e-01 | 0.215 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.094743e-01 | 0.215 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.094743e-01 | 0.215 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.117965e-01 | 0.213 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.180498e-01 | 0.209 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.180498e-01 | 0.209 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.180498e-01 | 0.209 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.180498e-01 | 0.209 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.180498e-01 | 0.209 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.193762e-01 | 0.208 | 1 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.201937e-01 | 0.207 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 6.237597e-01 | 0.205 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.237597e-01 | 0.205 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.237597e-01 | 0.205 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.237597e-01 | 0.205 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.237597e-01 | 0.205 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.237597e-01 | 0.205 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.237597e-01 | 0.205 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.269779e-01 | 0.203 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.269779e-01 | 0.203 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.269779e-01 | 0.203 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.269779e-01 | 0.203 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 6.269779e-01 | 0.203 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.269779e-01 | 0.203 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.269779e-01 | 0.203 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.269779e-01 | 0.203 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.269779e-01 | 0.203 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.269779e-01 | 0.203 | 1 | 1 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.269779e-01 | 0.203 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.269779e-01 | 0.203 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.269779e-01 | 0.203 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.269779e-01 | 0.203 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.269779e-01 | 0.203 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.269779e-01 | 0.203 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.269779e-01 | 0.203 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.269933e-01 | 0.203 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.269933e-01 | 0.203 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.284397e-01 | 0.202 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.284397e-01 | 0.202 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.284397e-01 | 0.202 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.284397e-01 | 0.202 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.348509e-01 | 0.197 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.350111e-01 | 0.197 | 1 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.353059e-01 | 0.197 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.416556e-01 | 0.193 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.416556e-01 | 0.193 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.430899e-01 | 0.192 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.475616e-01 | 0.189 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.484425e-01 | 0.188 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.484425e-01 | 0.188 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.484425e-01 | 0.188 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.484425e-01 | 0.188 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.484425e-01 | 0.188 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.484425e-01 | 0.188 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.484425e-01 | 0.188 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.484425e-01 | 0.188 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.484425e-01 | 0.188 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.550671e-01 | 0.184 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.556609e-01 | 0.183 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.562117e-01 | 0.183 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.566331e-01 | 0.183 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.566331e-01 | 0.183 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 6.584276e-01 | 0.181 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.584276e-01 | 0.181 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 6.584276e-01 | 0.181 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.584276e-01 | 0.181 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.584276e-01 | 0.181 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.584276e-01 | 0.181 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.591337e-01 | 0.181 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.591337e-01 | 0.181 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.614786e-01 | 0.179 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.680202e-01 | 0.175 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.680202e-01 | 0.175 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.698882e-01 | 0.174 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.760048e-01 | 0.170 | 1 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.760048e-01 | 0.170 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.760048e-01 | 0.170 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.760048e-01 | 0.170 | 1 | 1 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.760048e-01 | 0.170 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.760048e-01 | 0.170 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.760048e-01 | 0.170 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.760048e-01 | 0.170 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.760048e-01 | 0.170 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.760048e-01 | 0.170 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.760048e-01 | 0.170 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.760048e-01 | 0.170 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.760048e-01 | 0.170 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.760048e-01 | 0.170 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.760048e-01 | 0.170 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.760048e-01 | 0.170 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.760048e-01 | 0.170 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.760048e-01 | 0.170 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.760048e-01 | 0.170 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.760048e-01 | 0.170 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.760048e-01 | 0.170 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.782052e-01 | 0.169 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.782052e-01 | 0.169 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.793735e-01 | 0.168 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.822993e-01 | 0.166 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.822993e-01 | 0.166 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 6.822993e-01 | 0.166 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.822993e-01 | 0.166 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.832513e-01 | 0.165 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.832513e-01 | 0.165 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.832513e-01 | 0.165 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.832513e-01 | 0.165 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.833250e-01 | 0.165 | 1 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.839634e-01 | 0.165 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.839634e-01 | 0.165 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.839634e-01 | 0.165 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.839634e-01 | 0.165 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.868922e-01 | 0.163 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.868922e-01 | 0.163 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.868922e-01 | 0.163 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.868922e-01 | 0.163 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.868922e-01 | 0.163 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.885595e-01 | 0.162 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.904847e-01 | 0.161 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.904847e-01 | 0.161 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 6.904847e-01 | 0.161 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.904847e-01 | 0.161 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.904847e-01 | 0.161 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.904847e-01 | 0.161 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.933416e-01 | 0.159 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.933416e-01 | 0.159 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.944128e-01 | 0.158 | 1 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.027198e-01 | 0.153 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.029399e-01 | 0.153 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.038068e-01 | 0.153 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.038068e-01 | 0.153 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.043362e-01 | 0.152 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.043362e-01 | 0.152 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.043362e-01 | 0.152 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.043362e-01 | 0.152 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.050452e-01 | 0.152 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.069337e-01 | 0.151 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.072757e-01 | 0.150 | 1 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.082983e-01 | 0.150 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.082983e-01 | 0.150 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.082983e-01 | 0.150 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.082983e-01 | 0.150 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.082983e-01 | 0.150 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.082983e-01 | 0.150 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.084898e-01 | 0.150 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.100909e-01 | 0.149 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.111307e-01 | 0.148 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.152875e-01 | 0.146 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.166389e-01 | 0.145 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 7.185905e-01 | 0.144 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.185905e-01 | 0.144 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 7.185905e-01 | 0.144 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.185905e-01 | 0.144 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.185905e-01 | 0.144 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.185905e-01 | 0.144 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.185905e-01 | 0.144 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.185905e-01 | 0.144 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 7.185905e-01 | 0.144 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.185905e-01 | 0.144 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.185905e-01 | 0.144 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.200184e-01 | 0.143 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.200184e-01 | 0.143 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.200184e-01 | 0.143 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.200184e-01 | 0.143 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.200184e-01 | 0.143 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.200184e-01 | 0.143 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.200184e-01 | 0.143 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.222933e-01 | 0.141 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.224709e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.227649e-01 | 0.141 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.227649e-01 | 0.141 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.227649e-01 | 0.141 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.227649e-01 | 0.141 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.230912e-01 | 0.141 | 1 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.252432e-01 | 0.140 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.252432e-01 | 0.140 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.252432e-01 | 0.140 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.275155e-01 | 0.138 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.316108e-01 | 0.136 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.317944e-01 | 0.136 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.317944e-01 | 0.136 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.317944e-01 | 0.136 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.317944e-01 | 0.136 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.317944e-01 | 0.136 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.317944e-01 | 0.136 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.391653e-01 | 0.131 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.408368e-01 | 0.130 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.450282e-01 | 0.128 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.471382e-01 | 0.127 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.471382e-01 | 0.127 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.471382e-01 | 0.127 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.471382e-01 | 0.127 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.471382e-01 | 0.127 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.471382e-01 | 0.127 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.471382e-01 | 0.127 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.471382e-01 | 0.127 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.537724e-01 | 0.123 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.537724e-01 | 0.123 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.537724e-01 | 0.123 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.537724e-01 | 0.123 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.537724e-01 | 0.123 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.537724e-01 | 0.123 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.537724e-01 | 0.123 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.537724e-01 | 0.123 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.538859e-01 | 0.123 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.538859e-01 | 0.123 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.539472e-01 | 0.123 | 1 | 1 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.551290e-01 | 0.122 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.551290e-01 | 0.122 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.551290e-01 | 0.122 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.555809e-01 | 0.122 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.555809e-01 | 0.122 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.555809e-01 | 0.122 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.555809e-01 | 0.122 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.555809e-01 | 0.122 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.555809e-01 | 0.122 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.555809e-01 | 0.122 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.555809e-01 | 0.122 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.555809e-01 | 0.122 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.555809e-01 | 0.122 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.555809e-01 | 0.122 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.555809e-01 | 0.122 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.557538e-01 | 0.122 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.574270e-01 | 0.121 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.580275e-01 | 0.120 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.637066e-01 | 0.117 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.637066e-01 | 0.117 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.673966e-01 | 0.115 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.682586e-01 | 0.114 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.682586e-01 | 0.114 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.703661e-01 | 0.113 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.703661e-01 | 0.113 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.703661e-01 | 0.113 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.703661e-01 | 0.113 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.719682e-01 | 0.112 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.719682e-01 | 0.112 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.719682e-01 | 0.112 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.719682e-01 | 0.112 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.719682e-01 | 0.112 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.719682e-01 | 0.112 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.719682e-01 | 0.112 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.719682e-01 | 0.112 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.719682e-01 | 0.112 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.739010e-01 | 0.111 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.742760e-01 | 0.111 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.742760e-01 | 0.111 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.742760e-01 | 0.111 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.742760e-01 | 0.111 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.743467e-01 | 0.111 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.743467e-01 | 0.111 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.808671e-01 | 0.107 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.813004e-01 | 0.107 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.817364e-01 | 0.107 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.844828e-01 | 0.105 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.877108e-01 | 0.104 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.877108e-01 | 0.104 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.877108e-01 | 0.104 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.877108e-01 | 0.104 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.877108e-01 | 0.104 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.877108e-01 | 0.104 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.877108e-01 | 0.104 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.877108e-01 | 0.104 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.877108e-01 | 0.104 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.877108e-01 | 0.104 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.877108e-01 | 0.104 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.877108e-01 | 0.104 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.898086e-01 | 0.102 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.910869e-01 | 0.102 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.933568e-01 | 0.101 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.935280e-01 | 0.100 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.935280e-01 | 0.100 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.936090e-01 | 0.100 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.946417e-01 | 0.100 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.946417e-01 | 0.100 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.946417e-01 | 0.100 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.946417e-01 | 0.100 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.946417e-01 | 0.100 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.947925e-01 | 0.100 | 1 | 1 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.950329e-01 | 0.100 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.950329e-01 | 0.100 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.969751e-01 | 0.099 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.969751e-01 | 0.099 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 8.016123e-01 | 0.096 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.021483e-01 | 0.096 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.044311e-01 | 0.095 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.047139e-01 | 0.094 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.110726e-01 | 0.091 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.110726e-01 | 0.091 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.113996e-01 | 0.091 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.118081e-01 | 0.091 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.133490e-01 | 0.090 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.133490e-01 | 0.090 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.152966e-01 | 0.089 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.152966e-01 | 0.089 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.152966e-01 | 0.089 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.155941e-01 | 0.089 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.156188e-01 | 0.089 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 8.156188e-01 | 0.089 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 8.156188e-01 | 0.089 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.156188e-01 | 0.089 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 8.156188e-01 | 0.089 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 8.156188e-01 | 0.089 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.156188e-01 | 0.089 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 8.156188e-01 | 0.089 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.156188e-01 | 0.089 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 8.156188e-01 | 0.089 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.156188e-01 | 0.089 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.156188e-01 | 0.089 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 8.156188e-01 | 0.089 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.158860e-01 | 0.088 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.182350e-01 | 0.087 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.182350e-01 | 0.087 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.190606e-01 | 0.087 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.193964e-01 | 0.087 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.242425e-01 | 0.084 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.242834e-01 | 0.084 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.274855e-01 | 0.082 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.274855e-01 | 0.082 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.274855e-01 | 0.082 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.274855e-01 | 0.082 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.274855e-01 | 0.082 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.278710e-01 | 0.082 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.278710e-01 | 0.082 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.306638e-01 | 0.081 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.307013e-01 | 0.081 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.307013e-01 | 0.081 | 1 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.307859e-01 | 0.081 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.340716e-01 | 0.079 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.340716e-01 | 0.079 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.360142e-01 | 0.078 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.398593e-01 | 0.076 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.398593e-01 | 0.076 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.398593e-01 | 0.076 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.398593e-01 | 0.076 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.398593e-01 | 0.076 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.398593e-01 | 0.076 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.398593e-01 | 0.076 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.398593e-01 | 0.076 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.398593e-01 | 0.076 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.398593e-01 | 0.076 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.398593e-01 | 0.076 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.398593e-01 | 0.076 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.398593e-01 | 0.076 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.398593e-01 | 0.076 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.414395e-01 | 0.075 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.414395e-01 | 0.075 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.414416e-01 | 0.075 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.426606e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.426606e-01 | 0.074 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.438026e-01 | 0.074 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.481532e-01 | 0.072 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.511039e-01 | 0.070 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.511039e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.511039e-01 | 0.070 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.541008e-01 | 0.068 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.541008e-01 | 0.068 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.549813e-01 | 0.068 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.566645e-01 | 0.067 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.609142e-01 | 0.065 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.609142e-01 | 0.065 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.609142e-01 | 0.065 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.609142e-01 | 0.065 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.609142e-01 | 0.065 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.609142e-01 | 0.065 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.609142e-01 | 0.065 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.609142e-01 | 0.065 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.609142e-01 | 0.065 | 1 | 1 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.612763e-01 | 0.065 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.612763e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.651233e-01 | 0.063 | 1 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.657657e-01 | 0.063 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.657657e-01 | 0.063 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.657657e-01 | 0.063 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.657657e-01 | 0.063 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.658902e-01 | 0.063 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.665272e-01 | 0.062 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.665272e-01 | 0.062 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.665272e-01 | 0.062 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.675495e-01 | 0.062 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.698322e-01 | 0.061 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.704075e-01 | 0.060 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.717047e-01 | 0.060 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.735051e-01 | 0.059 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.735051e-01 | 0.059 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.758661e-01 | 0.058 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.758661e-01 | 0.058 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.768520e-01 | 0.057 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.788716e-01 | 0.056 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.790370e-01 | 0.056 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.792019e-01 | 0.056 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.792019e-01 | 0.056 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.792019e-01 | 0.056 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.792019e-01 | 0.056 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.792019e-01 | 0.056 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.792019e-01 | 0.056 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.792019e-01 | 0.056 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.792019e-01 | 0.056 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.804700e-01 | 0.055 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.804700e-01 | 0.055 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.814274e-01 | 0.055 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.837700e-01 | 0.054 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.853128e-01 | 0.053 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.853128e-01 | 0.053 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.856372e-01 | 0.053 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.871827e-01 | 0.052 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.873864e-01 | 0.052 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.922299e-01 | 0.050 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.923194e-01 | 0.049 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.923194e-01 | 0.049 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 8.923194e-01 | 0.049 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.930549e-01 | 0.049 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.938681e-01 | 0.049 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.941360e-01 | 0.049 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.941360e-01 | 0.049 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.950859e-01 | 0.048 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.950859e-01 | 0.048 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.950859e-01 | 0.048 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.950859e-01 | 0.048 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.950859e-01 | 0.048 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.950859e-01 | 0.048 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.950859e-01 | 0.048 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.954981e-01 | 0.048 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.964629e-01 | 0.047 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.967963e-01 | 0.047 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.984455e-01 | 0.047 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.030900e-01 | 0.044 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.034321e-01 | 0.044 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.040376e-01 | 0.044 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.043979e-01 | 0.044 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.043979e-01 | 0.044 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.043979e-01 | 0.044 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.043979e-01 | 0.044 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.051965e-01 | 0.043 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.051965e-01 | 0.043 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.072692e-01 | 0.042 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.075335e-01 | 0.042 | 1 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 9.088821e-01 | 0.041 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 9.088821e-01 | 0.041 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 9.088821e-01 | 0.041 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 9.088821e-01 | 0.041 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.088821e-01 | 0.041 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.088821e-01 | 0.041 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.088821e-01 | 0.041 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 9.088821e-01 | 0.041 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.088821e-01 | 0.041 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.088821e-01 | 0.041 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.088821e-01 | 0.041 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 9.088821e-01 | 0.041 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 9.088821e-01 | 0.041 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 9.088821e-01 | 0.041 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 9.088821e-01 | 0.041 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 9.088821e-01 | 0.041 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.088821e-01 | 0.041 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.089007e-01 | 0.041 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.100334e-01 | 0.041 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.122635e-01 | 0.040 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.129797e-01 | 0.040 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.132031e-01 | 0.039 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.132708e-01 | 0.039 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.132708e-01 | 0.039 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.146079e-01 | 0.039 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.146079e-01 | 0.039 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.146079e-01 | 0.039 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.153267e-01 | 0.038 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.179161e-01 | 0.037 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.198026e-01 | 0.036 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.199814e-01 | 0.036 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.199814e-01 | 0.036 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.207258e-01 | 0.036 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.207258e-01 | 0.036 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.207258e-01 | 0.036 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.208648e-01 | 0.036 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.208648e-01 | 0.036 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.208648e-01 | 0.036 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.208648e-01 | 0.036 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.208648e-01 | 0.036 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.208648e-01 | 0.036 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.208648e-01 | 0.036 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.208648e-01 | 0.036 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.208648e-01 | 0.036 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.208648e-01 | 0.036 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.208648e-01 | 0.036 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.208648e-01 | 0.036 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.208648e-01 | 0.036 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.227274e-01 | 0.035 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.237978e-01 | 0.034 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.237978e-01 | 0.034 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.252145e-01 | 0.034 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.274325e-01 | 0.033 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.274325e-01 | 0.033 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.274325e-01 | 0.033 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.274325e-01 | 0.033 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.278180e-01 | 0.033 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.278180e-01 | 0.033 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.278180e-01 | 0.033 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.284766e-01 | 0.032 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.297777e-01 | 0.032 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.299528e-01 | 0.032 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.299528e-01 | 0.032 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.311691e-01 | 0.031 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.312723e-01 | 0.031 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.312723e-01 | 0.031 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.312723e-01 | 0.031 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.312723e-01 | 0.031 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.312723e-01 | 0.031 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.312723e-01 | 0.031 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.312723e-01 | 0.031 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.312723e-01 | 0.031 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.312723e-01 | 0.031 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.312723e-01 | 0.031 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.320290e-01 | 0.031 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.320290e-01 | 0.031 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.320290e-01 | 0.031 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.320290e-01 | 0.031 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.320290e-01 | 0.031 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.343903e-01 | 0.029 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.343903e-01 | 0.029 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.367738e-01 | 0.028 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.394221e-01 | 0.027 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.394221e-01 | 0.027 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.394221e-01 | 0.027 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.397588e-01 | 0.027 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.403116e-01 | 0.027 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.403116e-01 | 0.027 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.403116e-01 | 0.027 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.403116e-01 | 0.027 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.403116e-01 | 0.027 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 9.403116e-01 | 0.027 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.403116e-01 | 0.027 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.403116e-01 | 0.027 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.403116e-01 | 0.027 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.403116e-01 | 0.027 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.403116e-01 | 0.027 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.407277e-01 | 0.027 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.409472e-01 | 0.026 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.409831e-01 | 0.026 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.410946e-01 | 0.026 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.417219e-01 | 0.026 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.434000e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.451130e-01 | 0.025 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.460468e-01 | 0.024 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.460468e-01 | 0.024 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.460468e-01 | 0.024 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.460468e-01 | 0.024 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.464935e-01 | 0.024 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.464935e-01 | 0.024 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.464935e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.464935e-01 | 0.024 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.481624e-01 | 0.023 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.481624e-01 | 0.023 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.481624e-01 | 0.023 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.481624e-01 | 0.023 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 9.481624e-01 | 0.023 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.481624e-01 | 0.023 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.485283e-01 | 0.023 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.487692e-01 | 0.023 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.500284e-01 | 0.022 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.505648e-01 | 0.022 | 1 | 0 |
| Influenza Infection | R-HSA-168255 | 9.511520e-01 | 0.022 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.519774e-01 | 0.021 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.526933e-01 | 0.021 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.528025e-01 | 0.021 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.549810e-01 | 0.020 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.549810e-01 | 0.020 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.549810e-01 | 0.020 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.549810e-01 | 0.020 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.549810e-01 | 0.020 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.549810e-01 | 0.020 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.549810e-01 | 0.020 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.549810e-01 | 0.020 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.564917e-01 | 0.019 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.572818e-01 | 0.019 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.572818e-01 | 0.019 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.572818e-01 | 0.019 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.609031e-01 | 0.017 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.609031e-01 | 0.017 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.609031e-01 | 0.017 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.609031e-01 | 0.017 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.609031e-01 | 0.017 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.609031e-01 | 0.017 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.609031e-01 | 0.017 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.609031e-01 | 0.017 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.609031e-01 | 0.017 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.619223e-01 | 0.017 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.620220e-01 | 0.017 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.625570e-01 | 0.017 | 1 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.643386e-01 | 0.016 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.647057e-01 | 0.016 | 1 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.647179e-01 | 0.016 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.652163e-01 | 0.015 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.655364e-01 | 0.015 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.659047e-01 | 0.015 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.659047e-01 | 0.015 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.660464e-01 | 0.015 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.660464e-01 | 0.015 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.660464e-01 | 0.015 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.660464e-01 | 0.015 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.660464e-01 | 0.015 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.660464e-01 | 0.015 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.660464e-01 | 0.015 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.662547e-01 | 0.015 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.687280e-01 | 0.014 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.700313e-01 | 0.013 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.705134e-01 | 0.013 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.705134e-01 | 0.013 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.705134e-01 | 0.013 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.705134e-01 | 0.013 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.705134e-01 | 0.013 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.705134e-01 | 0.013 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.705134e-01 | 0.013 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.705705e-01 | 0.013 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.719476e-01 | 0.012 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.725241e-01 | 0.012 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.730842e-01 | 0.012 | 1 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.733986e-01 | 0.012 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.733986e-01 | 0.012 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.741430e-01 | 0.011 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.741430e-01 | 0.011 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.741430e-01 | 0.011 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.743563e-01 | 0.011 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.743563e-01 | 0.011 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.743563e-01 | 0.011 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.743929e-01 | 0.011 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.743929e-01 | 0.011 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.743929e-01 | 0.011 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.743929e-01 | 0.011 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.743929e-01 | 0.011 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.743929e-01 | 0.011 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.743929e-01 | 0.011 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.743929e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.763989e-01 | 0.010 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.763989e-01 | 0.010 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.763989e-01 | 0.010 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.769709e-01 | 0.010 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.769709e-01 | 0.010 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.769758e-01 | 0.010 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.769758e-01 | 0.010 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.775087e-01 | 0.010 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.777622e-01 | 0.010 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.777622e-01 | 0.010 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.780135e-01 | 0.010 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.790704e-01 | 0.009 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.790704e-01 | 0.009 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.790704e-01 | 0.009 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.793304e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.799761e-01 | 0.009 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.806883e-01 | 0.008 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.806883e-01 | 0.008 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.806883e-01 | 0.008 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.806883e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.806883e-01 | 0.008 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.806883e-01 | 0.008 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.806883e-01 | 0.008 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.812726e-01 | 0.008 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.812726e-01 | 0.008 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.812726e-01 | 0.008 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.814477e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.814477e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.814477e-01 | 0.008 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.814477e-01 | 0.008 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.814584e-01 | 0.008 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.827892e-01 | 0.008 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.828734e-01 | 0.008 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.832296e-01 | 0.007 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.832296e-01 | 0.007 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.832296e-01 | 0.007 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.832296e-01 | 0.007 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.832296e-01 | 0.007 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.832296e-01 | 0.007 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.835619e-01 | 0.007 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.835619e-01 | 0.007 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.841862e-01 | 0.007 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.845955e-01 | 0.007 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.851022e-01 | 0.007 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.851022e-01 | 0.007 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.854366e-01 | 0.006 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.854366e-01 | 0.006 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.854366e-01 | 0.006 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.854366e-01 | 0.006 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.854366e-01 | 0.006 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.854366e-01 | 0.006 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.854411e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.854411e-01 | 0.006 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.854914e-01 | 0.006 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.860867e-01 | 0.006 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.862987e-01 | 0.006 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.866562e-01 | 0.006 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.866641e-01 | 0.006 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.869274e-01 | 0.006 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.871105e-01 | 0.006 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.873532e-01 | 0.006 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.873532e-01 | 0.006 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.873532e-01 | 0.006 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.873532e-01 | 0.006 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.873532e-01 | 0.006 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.873532e-01 | 0.006 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.875549e-01 | 0.005 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.885864e-01 | 0.005 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.885928e-01 | 0.005 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.885928e-01 | 0.005 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.885928e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.888282e-01 | 0.005 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.890177e-01 | 0.005 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.890177e-01 | 0.005 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.890177e-01 | 0.005 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.890177e-01 | 0.005 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.893099e-01 | 0.005 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.899083e-01 | 0.004 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.904632e-01 | 0.004 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.904632e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.904632e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.904632e-01 | 0.004 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.904632e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.906368e-01 | 0.004 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.907012e-01 | 0.004 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.910753e-01 | 0.004 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.911052e-01 | 0.004 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.912930e-01 | 0.004 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.917185e-01 | 0.004 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.917185e-01 | 0.004 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.917185e-01 | 0.004 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.917185e-01 | 0.004 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.920091e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.921099e-01 | 0.003 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.921782e-01 | 0.003 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.924140e-01 | 0.003 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.925074e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.928087e-01 | 0.003 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.928087e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.928087e-01 | 0.003 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.930269e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.930269e-01 | 0.003 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.937554e-01 | 0.003 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.938393e-01 | 0.003 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.938761e-01 | 0.003 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.939060e-01 | 0.003 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.941867e-01 | 0.003 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.945775e-01 | 0.002 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.945775e-01 | 0.002 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.945775e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.947381e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.950236e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.951033e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.951033e-01 | 0.002 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.951439e-01 | 0.002 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.951466e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.956712e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.956712e-01 | 0.002 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.957695e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.959114e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.959114e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.961405e-01 | 0.002 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.962574e-01 | 0.002 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.963354e-01 | 0.002 | 1 | 0 |
| Collagen formation | R-HSA-1474290 | 9.965150e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.965601e-01 | 0.001 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.969173e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.969173e-01 | 0.001 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.969173e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.971250e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.971406e-01 | 0.001 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.973232e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.973232e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.973952e-01 | 0.001 | 1 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.974772e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.976758e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.976888e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.977361e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.978817e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.979385e-01 | 0.001 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.979819e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.979819e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.979819e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.979819e-01 | 0.001 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.979819e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.982418e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.982477e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.982477e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.982876e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.984772e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.984785e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.984785e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.985389e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.986358e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.986789e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.987987e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.988530e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.989309e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.989424e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.989424e-01 | 0.000 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.990041e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.990504e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.990600e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.990600e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.992411e-01 | 0.000 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.992492e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.992513e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.992791e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.992791e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.992822e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.993355e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.993355e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.993482e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.993482e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.993659e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.993822e-01 | 0.000 | 1 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.994341e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.995086e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.995361e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.995734e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.996296e-01 | 0.000 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.996784e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.996784e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.996810e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.997017e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997071e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997071e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.997208e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997252e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997427e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.998026e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998068e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.998256e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998256e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998468e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998620e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998655e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998683e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.998740e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998805e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999238e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999242e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999300e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999304e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999321e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999411e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999556e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999614e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999644e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999665e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999685e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999704e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999723e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999755e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999835e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999851e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999857e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999930e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999938e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999943e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999946e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999954e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999965e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999965e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999969e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999977e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999985e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999989e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999993e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999995e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999998e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 1 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.353440e-09 | 8.869 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.097310e-09 | 8.509 | 1 | 0 |
| M Phase | R-HSA-68886 | 1.288254e-08 | 7.890 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.806871e-08 | 7.419 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.573834e-08 | 7.340 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.589705e-08 | 7.338 | 1 | 1 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.970845e-08 | 7.304 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.500433e-08 | 7.187 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.238041e-08 | 7.205 | 1 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.963116e-07 | 6.707 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.223794e-07 | 6.653 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.126719e-07 | 6.505 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.066971e-07 | 6.513 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.847320e-07 | 6.546 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.282784e-07 | 6.484 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.780428e-07 | 6.422 | 1 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.078761e-07 | 6.389 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.552620e-07 | 6.122 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.026923e-06 | 5.988 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.213171e-06 | 5.916 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.501681e-06 | 5.823 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.597802e-06 | 5.796 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.597802e-06 | 5.796 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.720266e-06 | 5.764 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.844050e-06 | 5.734 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.084429e-06 | 5.681 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.338177e-06 | 5.631 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.584990e-06 | 5.588 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.646466e-06 | 5.577 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.915905e-06 | 5.535 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.350107e-06 | 5.475 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.507769e-06 | 5.455 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.831476e-06 | 5.316 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.096136e-06 | 5.293 | 1 | 1 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.952005e-06 | 5.225 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.304699e-06 | 5.200 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.304699e-06 | 5.200 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.972126e-06 | 5.157 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.955289e-06 | 5.099 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.760262e-06 | 5.057 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.424769e-06 | 5.026 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.080568e-05 | 4.966 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.268858e-05 | 4.897 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.347139e-05 | 4.871 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.386714e-05 | 4.858 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.672994e-05 | 4.777 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.680063e-05 | 4.775 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.165736e-05 | 4.664 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.476343e-05 | 4.606 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.476343e-05 | 4.606 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.559550e-05 | 4.592 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.547789e-05 | 4.594 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.418277e-05 | 4.616 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.705247e-05 | 4.431 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.219293e-05 | 4.375 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.753528e-05 | 4.323 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.419509e-05 | 4.266 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.468518e-05 | 4.262 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.711182e-05 | 4.243 | 1 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.315161e-05 | 4.200 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.549243e-05 | 4.122 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.655207e-05 | 4.116 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.615403e-05 | 4.017 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.615403e-05 | 4.017 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.968938e-05 | 4.001 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.013797e-04 | 3.994 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.015417e-04 | 3.993 | 1 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.075975e-04 | 3.968 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.089924e-04 | 3.963 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.283995e-04 | 3.891 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.283995e-04 | 3.891 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.284373e-04 | 3.891 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.349072e-04 | 3.870 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.352335e-04 | 3.869 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.488260e-04 | 3.827 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.488260e-04 | 3.827 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.603479e-04 | 3.795 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.772127e-04 | 3.752 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.687003e-04 | 3.773 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.772127e-04 | 3.752 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.839852e-04 | 3.735 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.927671e-04 | 3.715 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.259956e-04 | 3.646 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.340855e-04 | 3.631 | 1 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.614292e-04 | 3.583 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.783051e-04 | 3.555 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.932318e-04 | 3.533 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.202794e-04 | 3.494 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.216965e-04 | 3.493 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.430890e-04 | 3.465 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.721928e-04 | 3.429 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.986020e-04 | 3.399 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.182762e-04 | 3.379 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.299623e-04 | 3.367 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.729062e-04 | 3.325 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.995765e-04 | 3.301 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.281057e-04 | 3.277 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.494112e-04 | 3.260 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.494112e-04 | 3.260 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.160520e-04 | 3.210 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.204130e-04 | 3.207 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.891139e-04 | 3.162 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.939459e-04 | 3.159 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.173004e-04 | 3.144 | 1 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.019227e-04 | 3.096 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.969170e-04 | 3.099 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.757155e-04 | 3.058 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.562385e-04 | 3.019 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.562385e-04 | 3.019 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.684177e-04 | 3.014 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.262733e-04 | 3.033 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 9.684177e-04 | 3.014 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.829732e-04 | 3.007 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.427324e-04 | 3.026 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.233698e-04 | 3.035 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.022518e-03 | 2.990 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.098490e-03 | 2.959 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.098490e-03 | 2.959 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.142032e-03 | 2.942 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.199516e-03 | 2.921 | 1 | 0 |
| Kinesins | R-HSA-983189 | 1.225859e-03 | 2.912 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.418806e-03 | 2.848 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.330791e-03 | 2.876 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.434579e-03 | 2.843 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.561967e-03 | 2.806 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.639564e-03 | 2.785 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.796344e-03 | 2.746 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.020294e-03 | 2.695 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.208607e-03 | 2.656 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.248564e-03 | 2.648 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.374358e-03 | 2.624 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.437457e-03 | 2.613 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.580064e-03 | 2.588 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.939123e-03 | 2.532 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.801580e-03 | 2.553 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.132706e-03 | 2.504 | 1 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.255850e-03 | 2.487 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.557577e-03 | 2.449 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.639749e-03 | 2.439 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.639749e-03 | 2.439 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.048078e-03 | 2.393 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.052131e-03 | 2.392 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.604962e-03 | 2.337 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.323274e-03 | 2.364 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.649962e-03 | 2.333 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.479514e-03 | 2.349 | 1 | 1 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.649962e-03 | 2.333 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.796483e-03 | 2.319 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.312040e-03 | 2.275 | 1 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.447596e-03 | 2.264 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.932847e-03 | 2.227 | 1 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.162000e-03 | 2.145 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.162000e-03 | 2.145 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.162000e-03 | 2.145 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.162000e-03 | 2.145 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.162000e-03 | 2.145 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.162000e-03 | 2.145 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.162000e-03 | 2.145 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.162000e-03 | 2.145 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.162000e-03 | 2.145 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.162000e-03 | 2.145 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.162000e-03 | 2.145 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.646716e-03 | 2.177 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.811315e-03 | 2.167 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.074747e-03 | 2.150 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.086586e-03 | 2.150 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.086586e-03 | 2.150 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.394284e-03 | 2.131 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.709021e-03 | 2.113 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.992537e-03 | 2.097 | 1 | 1 |
| Deubiquitination | R-HSA-5688426 | 8.102165e-03 | 2.091 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.146066e-03 | 2.089 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.864795e-03 | 2.052 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.957450e-03 | 2.048 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.577231e-03 | 2.019 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.016991e-02 | 1.993 | 1 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.467717e-03 | 2.024 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.011866e-02 | 1.995 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.359648e-03 | 2.029 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.092544e-03 | 2.041 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.097907e-02 | 1.959 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.106816e-02 | 1.956 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.106816e-02 | 1.956 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.106816e-02 | 1.956 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.156034e-02 | 1.937 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.175616e-02 | 1.930 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.175716e-02 | 1.930 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.198554e-02 | 1.921 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.205915e-02 | 1.919 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.205915e-02 | 1.919 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.230427e-02 | 1.910 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.312844e-02 | 1.882 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.341341e-02 | 1.872 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.388260e-02 | 1.858 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.402846e-02 | 1.853 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.431037e-02 | 1.844 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.466710e-02 | 1.834 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.634672e-02 | 1.787 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.634672e-02 | 1.787 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.634672e-02 | 1.787 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.634672e-02 | 1.787 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.634672e-02 | 1.787 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.681222e-02 | 1.774 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.608329e-02 | 1.794 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.489489e-02 | 1.827 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.698733e-02 | 1.770 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.715082e-02 | 1.766 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.763976e-02 | 1.754 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.843817e-02 | 1.734 | 1 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.855548e-02 | 1.732 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.003468e-02 | 1.698 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.056460e-02 | 1.687 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.099894e-02 | 1.678 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.099894e-02 | 1.678 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.100105e-02 | 1.678 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.122488e-02 | 1.673 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.170999e-02 | 1.663 | 1 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.202466e-02 | 1.657 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.266429e-02 | 1.645 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.285621e-02 | 1.641 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.561774e-02 | 1.591 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.819654e-02 | 1.550 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.561774e-02 | 1.591 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.662466e-02 | 1.575 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.819654e-02 | 1.550 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.476890e-02 | 1.606 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.527324e-02 | 1.597 | 1 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.561774e-02 | 1.591 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.864237e-02 | 1.543 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.819654e-02 | 1.550 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.819654e-02 | 1.550 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.479328e-02 | 1.606 | 1 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.922390e-02 | 1.534 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.923314e-02 | 1.534 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.006719e-02 | 1.522 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.006719e-02 | 1.522 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.057672e-02 | 1.515 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.109761e-02 | 1.507 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.109761e-02 | 1.507 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.275118e-02 | 1.485 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.334269e-02 | 1.477 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.453895e-02 | 1.462 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.453895e-02 | 1.462 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.453895e-02 | 1.462 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.612430e-02 | 1.442 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.702981e-02 | 1.431 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.702981e-02 | 1.431 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.777177e-02 | 1.423 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.785878e-02 | 1.422 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.959475e-02 | 1.402 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.059603e-02 | 1.392 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.141557e-02 | 1.383 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.330704e-02 | 1.363 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.330704e-02 | 1.363 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.330704e-02 | 1.363 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.327259e-02 | 1.364 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.327259e-02 | 1.364 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.926541e-02 | 1.307 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.926541e-02 | 1.307 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.276745e-02 | 1.369 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.619286e-02 | 1.335 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.619286e-02 | 1.335 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.825899e-02 | 1.316 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.041292e-02 | 1.297 | 1 | 1 |
| Recycling pathway of L1 | R-HSA-437239 | 4.380890e-02 | 1.358 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.619286e-02 | 1.335 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.501683e-02 | 1.347 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.330704e-02 | 1.363 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.624868e-02 | 1.335 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.997422e-02 | 1.301 | 1 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.327259e-02 | 1.364 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.831752e-02 | 1.316 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.679597e-02 | 1.330 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.619286e-02 | 1.335 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.120701e-02 | 1.291 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.120701e-02 | 1.291 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.139463e-02 | 1.289 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.380179e-02 | 1.269 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.416848e-02 | 1.266 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.448200e-02 | 1.264 | 1 | 1 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.472254e-02 | 1.262 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.472254e-02 | 1.262 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.472254e-02 | 1.262 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.505441e-02 | 1.259 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.527980e-02 | 1.257 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.754934e-02 | 1.240 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.754934e-02 | 1.240 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.876865e-02 | 1.231 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.892659e-02 | 1.230 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.892659e-02 | 1.230 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.911026e-02 | 1.228 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.408924e-02 | 1.193 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.535259e-02 | 1.185 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.578638e-02 | 1.182 | 1 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.650707e-02 | 1.177 | 1 | 1 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.678321e-02 | 1.175 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.370692e-02 | 1.132 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.370692e-02 | 1.132 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.370692e-02 | 1.132 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.409949e-02 | 1.075 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.417829e-02 | 1.130 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.417829e-02 | 1.130 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.417829e-02 | 1.130 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.417829e-02 | 1.130 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.249568e-02 | 1.084 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.249568e-02 | 1.084 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.091625e-02 | 1.092 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.941299e-02 | 1.159 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.192004e-02 | 1.087 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.192004e-02 | 1.087 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.192004e-02 | 1.087 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.547331e-02 | 1.122 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.219854e-02 | 1.141 | 1 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.919150e-02 | 1.160 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.192004e-02 | 1.087 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.977710e-02 | 1.098 | 1 | 1 |
| Netrin-1 signaling | R-HSA-373752 | 6.854487e-02 | 1.164 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.409949e-02 | 1.075 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.944409e-02 | 1.158 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.630083e-02 | 1.117 | 1 | 1 |
| Disorders of Nervous System Development | R-HSA-9697154 | 7.093883e-02 | 1.149 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 7.093883e-02 | 1.149 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 7.093883e-02 | 1.149 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.731370e-02 | 1.172 | 1 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.249568e-02 | 1.084 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.091625e-02 | 1.092 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.143802e-02 | 1.146 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.370692e-02 | 1.132 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.860973e-02 | 1.164 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.488411e-02 | 1.126 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.409949e-02 | 1.075 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.498125e-02 | 1.125 | 1 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 8.474088e-02 | 1.072 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.514212e-02 | 1.070 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.514212e-02 | 1.070 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.683620e-02 | 1.061 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.683620e-02 | 1.061 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.683620e-02 | 1.061 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.683620e-02 | 1.061 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.683620e-02 | 1.061 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.727834e-02 | 1.059 | 1 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.876215e-02 | 1.052 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.876215e-02 | 1.052 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.876215e-02 | 1.052 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.876215e-02 | 1.052 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.163109e-02 | 1.038 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.163372e-02 | 1.038 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.163372e-02 | 1.038 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.163372e-02 | 1.038 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 9.163372e-02 | 1.038 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.188345e-02 | 1.037 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.188345e-02 | 1.037 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.188345e-02 | 1.037 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.188345e-02 | 1.037 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.188345e-02 | 1.037 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.188345e-02 | 1.037 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.188345e-02 | 1.037 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.188345e-02 | 1.037 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.243531e-02 | 1.034 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.147760e-01 | 0.940 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.147760e-01 | 0.940 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.147760e-01 | 0.940 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.111644e-01 | 0.954 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.836011e-02 | 1.007 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 9.836011e-02 | 1.007 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.136618e-01 | 0.944 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.094455e-01 | 0.961 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.141452e-01 | 0.943 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.141452e-01 | 0.943 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.141452e-01 | 0.943 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.154568e-01 | 0.938 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.057254e-01 | 0.976 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.057254e-01 | 0.976 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.057254e-01 | 0.976 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.130544e-01 | 0.947 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.794172e-02 | 1.009 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.113284e-01 | 0.953 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.037810e-01 | 0.984 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.094455e-01 | 0.961 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.259702e-01 | 0.900 | 1 | 1 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.147760e-01 | 0.940 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 9.836011e-02 | 1.007 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.148329e-01 | 0.940 | 1 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.258822e-01 | 0.900 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.047277e-01 | 0.980 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.047277e-01 | 0.980 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.209399e-01 | 0.917 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.111644e-01 | 0.954 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.247925e-01 | 0.904 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.111644e-01 | 0.954 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.111644e-01 | 0.954 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.029901e-01 | 0.987 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.111644e-01 | 0.954 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.227285e-01 | 0.911 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.148329e-01 | 0.940 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.113284e-01 | 0.953 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.111644e-01 | 0.954 | 1 | 1 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.094455e-01 | 0.961 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.836011e-02 | 1.007 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.094455e-01 | 0.961 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.299370e-01 | 0.886 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.299370e-01 | 0.886 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.299370e-01 | 0.886 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.299370e-01 | 0.886 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.307672e-01 | 0.884 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.315254e-01 | 0.881 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.321220e-01 | 0.879 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.321220e-01 | 0.879 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.321220e-01 | 0.879 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.321220e-01 | 0.879 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.321220e-01 | 0.879 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.342628e-01 | 0.872 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.352314e-01 | 0.869 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.355914e-01 | 0.868 | 1 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.367195e-01 | 0.864 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.367195e-01 | 0.864 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.367195e-01 | 0.864 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.367195e-01 | 0.864 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.381797e-01 | 0.860 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.381797e-01 | 0.860 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.387568e-01 | 0.858 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.416402e-01 | 0.849 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.422671e-01 | 0.847 | 1 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.443014e-01 | 0.841 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.443014e-01 | 0.841 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.470208e-01 | 0.833 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.470208e-01 | 0.833 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 1.470208e-01 | 0.833 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.470208e-01 | 0.833 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.470208e-01 | 0.833 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.470208e-01 | 0.833 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.470208e-01 | 0.833 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.470208e-01 | 0.833 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.470208e-01 | 0.833 | 0 | 0 |
| Hydroxycarboxylic acid-binding receptors | R-HSA-3296197 | 1.470208e-01 | 0.833 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.471114e-01 | 0.832 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.471114e-01 | 0.832 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.473469e-01 | 0.832 | 1 | 1 |
| Translation initiation complex formation | R-HSA-72649 | 1.498461e-01 | 0.824 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.510132e-01 | 0.821 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.510132e-01 | 0.821 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.510132e-01 | 0.821 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.513324e-01 | 0.820 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.513783e-01 | 0.820 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.513783e-01 | 0.820 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.753293e-01 | 0.756 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.753293e-01 | 0.756 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.511118e-01 | 0.600 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.511118e-01 | 0.600 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.511118e-01 | 0.600 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.511118e-01 | 0.600 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 2.511118e-01 | 0.600 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.511118e-01 | 0.600 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 2.511118e-01 | 0.600 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.511118e-01 | 0.600 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.511118e-01 | 0.600 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.808161e-01 | 0.743 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.808161e-01 | 0.743 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.808161e-01 | 0.743 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.199345e-01 | 0.495 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.199345e-01 | 0.495 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.199345e-01 | 0.495 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.199345e-01 | 0.495 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.199345e-01 | 0.495 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.156054e-01 | 0.666 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.156054e-01 | 0.666 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.156054e-01 | 0.666 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.543238e-01 | 0.812 | 1 | 1 |
| Signaling by APC mutants | R-HSA-4839744 | 1.543238e-01 | 0.812 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.543238e-01 | 0.812 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.543238e-01 | 0.812 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.543238e-01 | 0.812 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.775860e-01 | 0.751 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.775860e-01 | 0.751 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.775860e-01 | 0.751 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.509211e-01 | 0.600 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.509211e-01 | 0.600 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.509211e-01 | 0.600 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.824360e-01 | 0.417 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.824360e-01 | 0.417 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.824360e-01 | 0.417 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.824360e-01 | 0.417 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.824360e-01 | 0.417 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.017281e-01 | 0.695 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.017281e-01 | 0.695 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.017281e-01 | 0.695 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.017281e-01 | 0.695 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.017281e-01 | 0.695 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.017281e-01 | 0.695 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.017281e-01 | 0.695 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.017281e-01 | 0.695 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.017281e-01 | 0.695 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.651055e-01 | 0.782 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 2.863729e-01 | 0.543 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.863729e-01 | 0.543 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.863729e-01 | 0.543 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.265749e-01 | 0.645 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.519593e-01 | 0.599 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.519593e-01 | 0.599 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.216379e-01 | 0.493 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.216379e-01 | 0.493 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.216379e-01 | 0.493 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.391967e-01 | 0.357 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.391967e-01 | 0.357 | 1 | 1 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.391967e-01 | 0.357 | 1 | 1 |
| Defective MAT1A causes MATD | R-HSA-5579024 | 4.391967e-01 | 0.357 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.391967e-01 | 0.357 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.391967e-01 | 0.357 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.231665e-01 | 0.651 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.231665e-01 | 0.651 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.777237e-01 | 0.556 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.781789e-01 | 0.749 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.564513e-01 | 0.448 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.564513e-01 | 0.448 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.157786e-01 | 0.666 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.924508e-01 | 0.716 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.037212e-01 | 0.518 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.507396e-01 | 0.601 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.298156e-01 | 0.482 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.298156e-01 | 0.482 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.905984e-01 | 0.408 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 3.905984e-01 | 0.408 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.702203e-01 | 0.769 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.687282e-01 | 0.571 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.687282e-01 | 0.571 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.558829e-01 | 0.449 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.558829e-01 | 0.449 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.558829e-01 | 0.449 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.393002e-01 | 0.621 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.263926e-01 | 0.645 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.284277e-01 | 0.484 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.239077e-01 | 0.373 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.392696e-01 | 0.621 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.241018e-01 | 0.489 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.020572e-01 | 0.520 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.828166e-01 | 0.548 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.657250e-01 | 0.576 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.792624e-01 | 0.554 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.074964e-01 | 0.390 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.074964e-01 | 0.390 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.074964e-01 | 0.390 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.562450e-01 | 0.341 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.562450e-01 | 0.341 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.562450e-01 | 0.341 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.616886e-01 | 0.442 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.616886e-01 | 0.442 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.931836e-01 | 0.405 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.522618e-01 | 0.453 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.328514e-01 | 0.364 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.328514e-01 | 0.364 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.328514e-01 | 0.364 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.328514e-01 | 0.364 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.328514e-01 | 0.364 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.208623e-01 | 0.494 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.208623e-01 | 0.494 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.139199e-01 | 0.503 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.742573e-01 | 0.427 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.358825e-01 | 0.361 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.358825e-01 | 0.361 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.358825e-01 | 0.361 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.358825e-01 | 0.361 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.030341e-01 | 0.395 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.030341e-01 | 0.395 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.199327e-01 | 0.377 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.367684e-01 | 0.360 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.516048e-01 | 0.345 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.332045e-01 | 0.363 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.481563e-01 | 0.605 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.368101e-01 | 0.360 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.644148e-01 | 0.578 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.368101e-01 | 0.360 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.402905e-01 | 0.468 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.231665e-01 | 0.651 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.561381e-01 | 0.341 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.144911e-01 | 0.669 | 1 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.643560e-01 | 0.784 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.863729e-01 | 0.543 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.825220e-01 | 0.739 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.562450e-01 | 0.341 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.128229e-01 | 0.505 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.535707e-01 | 0.596 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.265749e-01 | 0.645 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.543238e-01 | 0.812 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.216379e-01 | 0.493 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.564513e-01 | 0.448 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.918025e-01 | 0.717 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.284277e-01 | 0.484 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.562450e-01 | 0.341 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.503486e-01 | 0.601 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.503486e-01 | 0.601 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.540159e-01 | 0.595 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.216379e-01 | 0.493 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.781789e-01 | 0.749 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.564513e-01 | 0.448 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.428604e-01 | 0.465 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.536094e-01 | 0.451 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.536094e-01 | 0.451 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.805405e-01 | 0.420 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.687282e-01 | 0.571 | 1 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.020572e-01 | 0.520 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.616886e-01 | 0.442 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.740971e-01 | 0.759 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.828166e-01 | 0.548 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.391967e-01 | 0.357 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.777237e-01 | 0.556 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.564513e-01 | 0.448 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.263926e-01 | 0.645 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.239077e-01 | 0.373 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.894071e-01 | 0.723 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.562450e-01 | 0.341 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.433738e-01 | 0.464 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.993721e-01 | 0.399 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.492075e-01 | 0.457 | 1 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.074964e-01 | 0.390 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.989113e-01 | 0.701 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.993721e-01 | 0.399 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.885889e-01 | 0.540 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.433738e-01 | 0.464 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.054605e-01 | 0.515 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.602391e-01 | 0.795 | 1 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.870249e-01 | 0.542 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.808161e-01 | 0.743 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.519593e-01 | 0.599 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.777237e-01 | 0.556 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.435935e-01 | 0.613 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.564513e-01 | 0.448 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.851790e-01 | 0.732 | 1 | 1 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.905984e-01 | 0.408 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.558829e-01 | 0.449 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.428604e-01 | 0.465 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.258658e-01 | 0.646 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.328514e-01 | 0.364 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.362141e-01 | 0.360 | 1 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.353658e-01 | 0.361 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.477817e-01 | 0.349 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.559178e-01 | 0.807 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 3.280437e-01 | 0.484 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.208688e-01 | 0.376 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.037212e-01 | 0.518 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.562450e-01 | 0.341 | 1 | 1 |
| Cilium Assembly | R-HSA-5617833 | 2.895402e-01 | 0.538 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.859394e-01 | 0.731 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.354187e-01 | 0.474 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.808161e-01 | 0.743 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.982146e-01 | 0.703 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.648835e-01 | 0.783 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.693640e-01 | 0.570 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.716316e-01 | 0.430 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.535130e-01 | 0.343 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.221149e-01 | 0.492 | 1 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.239077e-01 | 0.373 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.805405e-01 | 0.420 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.586659e-01 | 0.800 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.536094e-01 | 0.451 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.457638e-01 | 0.609 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.057929e-01 | 0.392 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.377126e-01 | 0.359 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.777237e-01 | 0.556 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.074964e-01 | 0.390 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 2.017281e-01 | 0.695 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.451395e-01 | 0.611 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.838364e-01 | 0.736 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.553401e-01 | 0.342 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.519611e-01 | 0.599 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.922262e-01 | 0.406 | 1 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.766050e-01 | 0.424 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.590472e-01 | 0.445 | 1 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.753293e-01 | 0.756 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.511118e-01 | 0.600 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.511118e-01 | 0.600 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.199345e-01 | 0.495 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.199345e-01 | 0.495 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.199345e-01 | 0.495 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.199345e-01 | 0.495 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.775860e-01 | 0.751 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.824360e-01 | 0.417 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.824360e-01 | 0.417 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.391967e-01 | 0.357 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.391967e-01 | 0.357 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.777237e-01 | 0.556 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.644148e-01 | 0.578 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.533583e-01 | 0.596 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.558829e-01 | 0.449 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.262155e-01 | 0.645 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.500246e-01 | 0.456 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.100628e-01 | 0.678 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.616886e-01 | 0.442 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.280437e-01 | 0.484 | 1 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.635008e-01 | 0.439 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.030341e-01 | 0.395 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.444273e-01 | 0.463 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.066184e-01 | 0.391 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.901131e-01 | 0.721 | 1 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.725131e-01 | 0.763 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.144911e-01 | 0.669 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.809356e-01 | 0.551 | 1 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.861020e-01 | 0.413 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.032188e-01 | 0.692 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.777237e-01 | 0.556 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.993721e-01 | 0.399 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 2.777237e-01 | 0.556 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.569963e-01 | 0.447 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.680851e-01 | 0.572 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.564513e-01 | 0.448 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.564513e-01 | 0.448 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.298156e-01 | 0.482 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.635008e-01 | 0.439 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.454929e-01 | 0.462 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.993721e-01 | 0.399 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.894001e-01 | 0.723 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.115965e-01 | 0.674 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.069108e-01 | 0.513 | 1 | 1 |
| DARPP-32 events | R-HSA-180024 | 4.358825e-01 | 0.361 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.891980e-01 | 0.723 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.492075e-01 | 0.457 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.057929e-01 | 0.392 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.808161e-01 | 0.743 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 2.863729e-01 | 0.543 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.519593e-01 | 0.599 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.216379e-01 | 0.493 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.924508e-01 | 0.716 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.277133e-01 | 0.485 | 1 | 1 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.492075e-01 | 0.457 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.255341e-01 | 0.647 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.145295e-01 | 0.502 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.392696e-01 | 0.621 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.667964e-01 | 0.778 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.181418e-01 | 0.379 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.519611e-01 | 0.599 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.699782e-01 | 0.569 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.428604e-01 | 0.465 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.315636e-01 | 0.635 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.341297e-01 | 0.631 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.702203e-01 | 0.769 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.393002e-01 | 0.621 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.080326e-01 | 0.682 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.808161e-01 | 0.743 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.199345e-01 | 0.495 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.216379e-01 | 0.493 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.216379e-01 | 0.493 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.037212e-01 | 0.518 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.905984e-01 | 0.408 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.558829e-01 | 0.449 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.054605e-01 | 0.515 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.818102e-01 | 0.418 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.680851e-01 | 0.572 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.931836e-01 | 0.405 | 1 | 1 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.328514e-01 | 0.364 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.343006e-01 | 0.630 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.829927e-01 | 0.548 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.856091e-01 | 0.544 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.186723e-01 | 0.497 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.691672e-01 | 0.433 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.535707e-01 | 0.596 | 1 | 1 |
| Protein hydroxylation | R-HSA-9629569 | 4.328514e-01 | 0.364 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.059808e-01 | 0.514 | 1 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.368101e-01 | 0.360 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.156054e-01 | 0.666 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.216379e-01 | 0.493 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.071391e-01 | 0.684 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.905984e-01 | 0.408 | 1 | 1 |
| PECAM1 interactions | R-HSA-210990 | 3.905984e-01 | 0.408 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.146193e-01 | 0.382 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.629449e-01 | 0.788 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.071391e-01 | 0.684 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.231665e-01 | 0.651 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.818102e-01 | 0.418 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.052688e-01 | 0.392 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.228534e-01 | 0.652 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.777237e-01 | 0.556 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.509211e-01 | 0.600 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.824360e-01 | 0.417 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.863729e-01 | 0.543 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.216379e-01 | 0.493 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.391967e-01 | 0.357 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.564513e-01 | 0.448 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.020572e-01 | 0.520 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.020572e-01 | 0.520 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.186723e-01 | 0.497 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.562450e-01 | 0.341 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.562450e-01 | 0.341 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.535130e-01 | 0.343 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.764823e-01 | 0.424 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.519593e-01 | 0.599 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.523476e-01 | 0.598 | 1 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.543238e-01 | 0.812 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.216379e-01 | 0.493 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.777237e-01 | 0.556 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.905984e-01 | 0.408 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.693640e-01 | 0.570 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.239077e-01 | 0.373 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.199327e-01 | 0.377 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.535130e-01 | 0.343 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.064701e-01 | 0.514 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 1.808161e-01 | 0.743 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.074964e-01 | 0.390 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.702203e-01 | 0.769 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.938978e-01 | 0.405 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.199327e-01 | 0.377 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.355340e-01 | 0.361 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.332045e-01 | 0.363 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.564513e-01 | 0.448 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.284277e-01 | 0.484 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.569212e-01 | 0.340 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.569212e-01 | 0.340 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.569212e-01 | 0.340 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.569212e-01 | 0.340 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.577961e-01 | 0.339 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.577961e-01 | 0.339 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.577961e-01 | 0.339 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.681604e-01 | 0.330 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.701400e-01 | 0.328 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.736970e-01 | 0.324 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.736970e-01 | 0.324 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.745175e-01 | 0.324 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.767647e-01 | 0.322 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 4.776882e-01 | 0.321 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.781227e-01 | 0.320 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.781227e-01 | 0.320 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.822614e-01 | 0.317 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.822614e-01 | 0.317 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.875076e-01 | 0.312 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.875076e-01 | 0.312 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 4.875076e-01 | 0.312 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.875076e-01 | 0.312 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.875076e-01 | 0.312 | 1 | 1 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 4.875076e-01 | 0.312 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.875076e-01 | 0.312 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.881783e-01 | 0.311 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.907436e-01 | 0.309 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.907436e-01 | 0.309 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.907436e-01 | 0.309 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.907436e-01 | 0.309 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.907436e-01 | 0.309 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.907436e-01 | 0.309 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.907436e-01 | 0.309 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.907436e-01 | 0.309 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 4.907436e-01 | 0.309 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.922100e-01 | 0.308 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.981406e-01 | 0.303 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.061882e-01 | 0.296 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.061882e-01 | 0.296 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.061882e-01 | 0.296 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.087198e-01 | 0.294 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.097660e-01 | 0.293 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.108372e-01 | 0.292 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.118361e-01 | 0.291 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.126832e-01 | 0.290 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.176198e-01 | 0.286 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.176198e-01 | 0.286 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.176198e-01 | 0.286 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.176198e-01 | 0.286 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.182404e-01 | 0.285 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.182404e-01 | 0.285 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.182404e-01 | 0.285 | 1 | 1 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 5.190718e-01 | 0.285 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.200440e-01 | 0.284 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.269189e-01 | 0.278 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.274015e-01 | 0.278 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.295263e-01 | 0.276 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.295263e-01 | 0.276 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.295263e-01 | 0.276 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.295263e-01 | 0.276 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.337623e-01 | 0.273 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.375552e-01 | 0.270 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.375552e-01 | 0.270 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.375552e-01 | 0.270 | 1 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.375552e-01 | 0.270 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.375552e-01 | 0.270 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.375552e-01 | 0.270 | 1 | 1 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.375552e-01 | 0.270 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.375552e-01 | 0.270 | 0 | 0 |
| Terminal pathway of complement | R-HSA-166665 | 5.375552e-01 | 0.270 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.375552e-01 | 0.270 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.375552e-01 | 0.270 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.375552e-01 | 0.270 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.375552e-01 | 0.270 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.375552e-01 | 0.270 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.375552e-01 | 0.270 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.375552e-01 | 0.270 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.375552e-01 | 0.270 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.379533e-01 | 0.269 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.379533e-01 | 0.269 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.379533e-01 | 0.269 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.384642e-01 | 0.269 | 1 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.385983e-01 | 0.269 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.415264e-01 | 0.266 | 1 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.465291e-01 | 0.262 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.465291e-01 | 0.262 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.465291e-01 | 0.262 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.465291e-01 | 0.262 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.465291e-01 | 0.262 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.465291e-01 | 0.262 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.465291e-01 | 0.262 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.465291e-01 | 0.262 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.465291e-01 | 0.262 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.485132e-01 | 0.261 | 1 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.506859e-01 | 0.259 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.522341e-01 | 0.258 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.522341e-01 | 0.258 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.522341e-01 | 0.258 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.522341e-01 | 0.258 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.522341e-01 | 0.258 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.525900e-01 | 0.258 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.559447e-01 | 0.255 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.572497e-01 | 0.254 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.572497e-01 | 0.254 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.572497e-01 | 0.254 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 5.572497e-01 | 0.254 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.572497e-01 | 0.254 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.618502e-01 | 0.250 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.618502e-01 | 0.250 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.732041e-01 | 0.242 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.739682e-01 | 0.241 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.742022e-01 | 0.241 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.742022e-01 | 0.241 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.742022e-01 | 0.241 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.742022e-01 | 0.241 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.742022e-01 | 0.241 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.742022e-01 | 0.241 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 5.742022e-01 | 0.241 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.742022e-01 | 0.241 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.742776e-01 | 0.241 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.742776e-01 | 0.241 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.742776e-01 | 0.241 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 5.742776e-01 | 0.241 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.742776e-01 | 0.241 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.742776e-01 | 0.241 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 5.742776e-01 | 0.241 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.761036e-01 | 0.239 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.761036e-01 | 0.239 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.785817e-01 | 0.238 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.785817e-01 | 0.238 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.800663e-01 | 0.237 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.800663e-01 | 0.237 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.800663e-01 | 0.237 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.800663e-01 | 0.237 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.800663e-01 | 0.237 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.800663e-01 | 0.237 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.800663e-01 | 0.237 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 5.800663e-01 | 0.237 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.800663e-01 | 0.237 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.800663e-01 | 0.237 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.810498e-01 | 0.236 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.813219e-01 | 0.236 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.813219e-01 | 0.236 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.813219e-01 | 0.236 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.949669e-01 | 0.226 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.949669e-01 | 0.226 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.956301e-01 | 0.225 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.956301e-01 | 0.225 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.956301e-01 | 0.225 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.956301e-01 | 0.225 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.956301e-01 | 0.225 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.956301e-01 | 0.225 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.956301e-01 | 0.225 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.979309e-01 | 0.223 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.998691e-01 | 0.222 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.998691e-01 | 0.222 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.006221e-01 | 0.221 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.006221e-01 | 0.221 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.006221e-01 | 0.221 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.006221e-01 | 0.221 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.006221e-01 | 0.221 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.006221e-01 | 0.221 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.018192e-01 | 0.221 | 1 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.041012e-01 | 0.219 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.123996e-01 | 0.213 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.123996e-01 | 0.213 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.123996e-01 | 0.213 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.125191e-01 | 0.213 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.138620e-01 | 0.212 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.162716e-01 | 0.210 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.186718e-01 | 0.209 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.186718e-01 | 0.209 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.186718e-01 | 0.209 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.186718e-01 | 0.209 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.186718e-01 | 0.209 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.186718e-01 | 0.209 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.186718e-01 | 0.209 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.186718e-01 | 0.209 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.186718e-01 | 0.209 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.186718e-01 | 0.209 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.186718e-01 | 0.209 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.186718e-01 | 0.209 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.186718e-01 | 0.209 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.186718e-01 | 0.209 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.186718e-01 | 0.209 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.186718e-01 | 0.209 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.257853e-01 | 0.204 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.257853e-01 | 0.204 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.257853e-01 | 0.204 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.257853e-01 | 0.204 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.298896e-01 | 0.201 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.333447e-01 | 0.198 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.361878e-01 | 0.196 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.361878e-01 | 0.196 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.361878e-01 | 0.196 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.374836e-01 | 0.196 | 1 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.392048e-01 | 0.194 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.392048e-01 | 0.194 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.392048e-01 | 0.194 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.392048e-01 | 0.194 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.392048e-01 | 0.194 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.419027e-01 | 0.193 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.430559e-01 | 0.192 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.435788e-01 | 0.191 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.467069e-01 | 0.189 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.467069e-01 | 0.189 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.491711e-01 | 0.188 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.496995e-01 | 0.187 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.496995e-01 | 0.187 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.496995e-01 | 0.187 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.496995e-01 | 0.187 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.537303e-01 | 0.185 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.537303e-01 | 0.185 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.537303e-01 | 0.185 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.537303e-01 | 0.185 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.537303e-01 | 0.185 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.537303e-01 | 0.185 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.537303e-01 | 0.185 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.537303e-01 | 0.185 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.537303e-01 | 0.185 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.537303e-01 | 0.185 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.537303e-01 | 0.185 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.537303e-01 | 0.185 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.537303e-01 | 0.185 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.553698e-01 | 0.184 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.553698e-01 | 0.184 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.553698e-01 | 0.184 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.553698e-01 | 0.184 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.609334e-01 | 0.180 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.630869e-01 | 0.178 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.630869e-01 | 0.178 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.630869e-01 | 0.178 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.630869e-01 | 0.178 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.712362e-01 | 0.173 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.723817e-01 | 0.172 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.723817e-01 | 0.172 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.723817e-01 | 0.172 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.723817e-01 | 0.172 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 6.723817e-01 | 0.172 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.738135e-01 | 0.171 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.780485e-01 | 0.169 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.788654e-01 | 0.168 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.789419e-01 | 0.168 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 6.789419e-01 | 0.168 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.789419e-01 | 0.168 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.789419e-01 | 0.168 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.789419e-01 | 0.168 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.852935e-01 | 0.164 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.853845e-01 | 0.164 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.855675e-01 | 0.164 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.855675e-01 | 0.164 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.855675e-01 | 0.164 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.855675e-01 | 0.164 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.855675e-01 | 0.164 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.855675e-01 | 0.164 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.855675e-01 | 0.164 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.855675e-01 | 0.164 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.855675e-01 | 0.164 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.855675e-01 | 0.164 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.855675e-01 | 0.164 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.855675e-01 | 0.164 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.855675e-01 | 0.164 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.871963e-01 | 0.163 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.914095e-01 | 0.160 | 1 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.915192e-01 | 0.160 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.915192e-01 | 0.160 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.915192e-01 | 0.160 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.920405e-01 | 0.160 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.935519e-01 | 0.159 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.938563e-01 | 0.159 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.938563e-01 | 0.159 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.938563e-01 | 0.159 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.938563e-01 | 0.159 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.938563e-01 | 0.159 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.942682e-01 | 0.158 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.942682e-01 | 0.158 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.942682e-01 | 0.158 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.942682e-01 | 0.158 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.942682e-01 | 0.158 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.942682e-01 | 0.158 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.988492e-01 | 0.156 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.989387e-01 | 0.156 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.994214e-01 | 0.155 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.044136e-01 | 0.152 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.055717e-01 | 0.151 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.080201e-01 | 0.150 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.084907e-01 | 0.150 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.084907e-01 | 0.150 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.141534e-01 | 0.146 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.141534e-01 | 0.146 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.141534e-01 | 0.146 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.144792e-01 | 0.146 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.144792e-01 | 0.146 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.144792e-01 | 0.146 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.144792e-01 | 0.146 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.144792e-01 | 0.146 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.144792e-01 | 0.146 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.144792e-01 | 0.146 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.144792e-01 | 0.146 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.144792e-01 | 0.146 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.144792e-01 | 0.146 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.144792e-01 | 0.146 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.144792e-01 | 0.146 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.144792e-01 | 0.146 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.157979e-01 | 0.145 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.185256e-01 | 0.144 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.185256e-01 | 0.144 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.219862e-01 | 0.141 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.219862e-01 | 0.141 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.219862e-01 | 0.141 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.219862e-01 | 0.141 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.233317e-01 | 0.141 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.233317e-01 | 0.141 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.233317e-01 | 0.141 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.247353e-01 | 0.140 | 1 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.247353e-01 | 0.140 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.249843e-01 | 0.140 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.333082e-01 | 0.135 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.333082e-01 | 0.135 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.333082e-01 | 0.135 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.333082e-01 | 0.135 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.344730e-01 | 0.134 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.370723e-01 | 0.132 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.373839e-01 | 0.132 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.373839e-01 | 0.132 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.394818e-01 | 0.131 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.402630e-01 | 0.131 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 7.402630e-01 | 0.131 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.407340e-01 | 0.130 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.407340e-01 | 0.130 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 7.407340e-01 | 0.130 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.407340e-01 | 0.130 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.407340e-01 | 0.130 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.407340e-01 | 0.130 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.407340e-01 | 0.130 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.407340e-01 | 0.130 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.407340e-01 | 0.130 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.407340e-01 | 0.130 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.407340e-01 | 0.130 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.407340e-01 | 0.130 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.502907e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.502907e-01 | 0.125 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.502907e-01 | 0.125 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.502907e-01 | 0.125 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.502907e-01 | 0.125 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.513589e-01 | 0.124 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.513589e-01 | 0.124 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.513589e-01 | 0.124 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.513589e-01 | 0.124 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.550413e-01 | 0.122 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.550863e-01 | 0.122 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.550863e-01 | 0.122 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.550863e-01 | 0.122 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.550863e-01 | 0.122 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.550863e-01 | 0.122 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.550863e-01 | 0.122 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.550863e-01 | 0.122 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.609442e-01 | 0.119 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.620621e-01 | 0.118 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.629928e-01 | 0.117 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.629928e-01 | 0.117 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.645760e-01 | 0.117 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.645760e-01 | 0.117 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.645760e-01 | 0.117 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.645760e-01 | 0.117 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.645760e-01 | 0.117 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.645760e-01 | 0.117 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.645760e-01 | 0.117 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.645760e-01 | 0.117 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.649931e-01 | 0.116 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.649931e-01 | 0.116 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.649931e-01 | 0.116 | 1 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.649931e-01 | 0.116 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.649931e-01 | 0.116 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.683466e-01 | 0.114 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.683466e-01 | 0.114 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.692199e-01 | 0.114 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.692199e-01 | 0.114 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.692199e-01 | 0.114 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.692199e-01 | 0.114 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.692199e-01 | 0.114 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.721110e-01 | 0.112 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.743511e-01 | 0.111 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.751861e-01 | 0.111 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 7.814565e-01 | 0.107 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.814565e-01 | 0.107 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.826801e-01 | 0.106 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.826801e-01 | 0.106 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.826801e-01 | 0.106 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.826801e-01 | 0.106 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.826801e-01 | 0.106 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.828748e-01 | 0.106 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.862268e-01 | 0.104 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.862268e-01 | 0.104 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.862268e-01 | 0.104 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.862268e-01 | 0.104 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.862268e-01 | 0.104 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.862268e-01 | 0.104 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.862268e-01 | 0.104 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.862268e-01 | 0.104 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.862268e-01 | 0.104 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.862268e-01 | 0.104 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.862268e-01 | 0.104 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.862268e-01 | 0.104 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.862268e-01 | 0.104 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.862268e-01 | 0.104 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.868432e-01 | 0.104 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.868788e-01 | 0.104 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.868788e-01 | 0.104 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.926175e-01 | 0.101 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.932409e-01 | 0.101 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.932409e-01 | 0.101 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.954847e-01 | 0.099 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.993053e-01 | 0.097 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.993053e-01 | 0.097 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.993053e-01 | 0.097 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.995239e-01 | 0.097 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.018898e-01 | 0.096 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.018898e-01 | 0.096 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.058876e-01 | 0.094 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.058876e-01 | 0.094 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.058876e-01 | 0.094 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.058876e-01 | 0.094 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.058876e-01 | 0.094 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.058876e-01 | 0.094 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.058876e-01 | 0.094 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.058876e-01 | 0.094 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.058876e-01 | 0.094 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.058876e-01 | 0.094 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.058876e-01 | 0.094 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.058876e-01 | 0.094 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.058876e-01 | 0.094 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.058876e-01 | 0.094 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.079080e-01 | 0.093 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.133648e-01 | 0.090 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.133648e-01 | 0.090 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.133648e-01 | 0.090 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.154013e-01 | 0.089 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.181048e-01 | 0.087 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.190544e-01 | 0.087 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.192040e-01 | 0.087 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.192040e-01 | 0.087 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.192040e-01 | 0.087 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.225588e-01 | 0.085 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.229648e-01 | 0.085 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.229648e-01 | 0.085 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.237413e-01 | 0.084 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.237413e-01 | 0.084 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.237413e-01 | 0.084 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.237413e-01 | 0.084 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.237413e-01 | 0.084 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.237413e-01 | 0.084 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.237413e-01 | 0.084 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.237413e-01 | 0.084 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.237413e-01 | 0.084 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.237413e-01 | 0.084 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.265370e-01 | 0.083 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.265370e-01 | 0.083 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.265370e-01 | 0.083 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.265370e-01 | 0.083 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.265370e-01 | 0.083 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.288494e-01 | 0.082 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.295019e-01 | 0.081 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.295019e-01 | 0.081 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.301593e-01 | 0.081 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.301593e-01 | 0.081 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.316395e-01 | 0.080 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.324871e-01 | 0.080 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.324871e-01 | 0.080 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.363809e-01 | 0.078 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.381994e-01 | 0.077 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.381994e-01 | 0.077 | 1 | 1 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.388661e-01 | 0.076 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.388661e-01 | 0.076 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.399538e-01 | 0.076 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.399538e-01 | 0.076 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.399538e-01 | 0.076 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.399538e-01 | 0.076 | 1 | 1 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.399538e-01 | 0.076 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.399538e-01 | 0.076 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.399538e-01 | 0.076 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.399538e-01 | 0.076 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.399538e-01 | 0.076 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.399538e-01 | 0.076 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.399538e-01 | 0.076 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.399538e-01 | 0.076 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.399538e-01 | 0.076 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.405395e-01 | 0.075 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.422913e-01 | 0.075 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.422913e-01 | 0.075 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.427556e-01 | 0.074 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.427556e-01 | 0.074 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.471174e-01 | 0.072 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.482095e-01 | 0.071 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.490723e-01 | 0.071 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.503662e-01 | 0.070 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.503662e-01 | 0.070 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.503959e-01 | 0.070 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.503959e-01 | 0.070 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.503959e-01 | 0.070 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.503959e-01 | 0.070 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.530187e-01 | 0.069 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.546759e-01 | 0.068 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.546759e-01 | 0.068 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.546759e-01 | 0.068 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.546759e-01 | 0.068 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.546759e-01 | 0.068 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.546759e-01 | 0.068 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.546759e-01 | 0.068 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.546759e-01 | 0.068 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.546759e-01 | 0.068 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.584262e-01 | 0.066 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.595061e-01 | 0.066 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.611689e-01 | 0.065 | 1 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.611689e-01 | 0.065 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.627073e-01 | 0.064 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.637101e-01 | 0.064 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.644875e-01 | 0.063 | 1 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.680446e-01 | 0.061 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.680446e-01 | 0.061 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.680446e-01 | 0.061 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.680446e-01 | 0.061 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.680446e-01 | 0.061 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.693923e-01 | 0.061 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.698655e-01 | 0.061 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.712268e-01 | 0.060 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.712268e-01 | 0.060 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.712268e-01 | 0.060 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.712268e-01 | 0.060 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.721019e-01 | 0.059 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.759705e-01 | 0.058 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.766445e-01 | 0.057 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.780451e-01 | 0.056 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.801842e-01 | 0.055 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.801842e-01 | 0.055 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.801842e-01 | 0.055 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.801842e-01 | 0.055 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.801842e-01 | 0.055 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.801842e-01 | 0.055 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.801842e-01 | 0.055 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.801842e-01 | 0.055 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.845674e-01 | 0.053 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.856941e-01 | 0.053 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.856941e-01 | 0.053 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.869798e-01 | 0.052 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.880078e-01 | 0.052 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.889898e-01 | 0.051 | 1 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.889917e-01 | 0.051 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.893574e-01 | 0.051 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.893574e-01 | 0.051 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.893574e-01 | 0.051 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.893574e-01 | 0.051 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.906132e-01 | 0.050 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.912077e-01 | 0.050 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.912077e-01 | 0.050 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.912077e-01 | 0.050 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.912077e-01 | 0.050 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.912077e-01 | 0.050 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.912077e-01 | 0.050 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.912077e-01 | 0.050 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.912077e-01 | 0.050 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.912077e-01 | 0.050 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.912077e-01 | 0.050 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.912077e-01 | 0.050 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.933599e-01 | 0.049 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.975065e-01 | 0.047 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.975065e-01 | 0.047 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.975065e-01 | 0.047 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.989026e-01 | 0.046 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.994890e-01 | 0.046 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.012175e-01 | 0.045 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.012175e-01 | 0.045 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.012175e-01 | 0.045 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.042615e-01 | 0.044 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.045187e-01 | 0.044 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.045880e-01 | 0.044 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.050935e-01 | 0.043 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.103069e-01 | 0.041 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.103069e-01 | 0.041 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.103069e-01 | 0.041 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.103069e-01 | 0.041 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.103069e-01 | 0.041 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.114338e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.121526e-01 | 0.040 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.151758e-01 | 0.038 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.185604e-01 | 0.037 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.185604e-01 | 0.037 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.185604e-01 | 0.037 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.185604e-01 | 0.037 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.185604e-01 | 0.037 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.185604e-01 | 0.037 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.185604e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.185604e-01 | 0.037 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.186001e-01 | 0.037 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.187168e-01 | 0.037 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.187168e-01 | 0.037 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.248174e-01 | 0.034 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.248174e-01 | 0.034 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.250056e-01 | 0.034 | 1 | 1 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.254770e-01 | 0.034 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.254833e-01 | 0.034 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.254833e-01 | 0.034 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.258421e-01 | 0.033 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.260549e-01 | 0.033 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.260549e-01 | 0.033 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.260549e-01 | 0.033 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.260549e-01 | 0.033 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.260549e-01 | 0.033 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.260549e-01 | 0.033 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.260549e-01 | 0.033 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.277959e-01 | 0.033 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.279700e-01 | 0.032 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.290898e-01 | 0.032 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.299370e-01 | 0.032 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.304840e-01 | 0.031 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.304840e-01 | 0.031 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.328601e-01 | 0.030 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.328601e-01 | 0.030 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.328601e-01 | 0.030 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.328601e-01 | 0.030 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.328601e-01 | 0.030 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.344037e-01 | 0.029 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.390394e-01 | 0.027 | 1 | 1 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.390394e-01 | 0.027 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.390394e-01 | 0.027 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.390394e-01 | 0.027 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.390394e-01 | 0.027 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.390394e-01 | 0.027 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.390394e-01 | 0.027 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.406266e-01 | 0.027 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.406266e-01 | 0.027 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.412476e-01 | 0.026 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.415026e-01 | 0.026 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.446503e-01 | 0.025 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.446503e-01 | 0.025 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.446503e-01 | 0.025 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.446503e-01 | 0.025 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.446503e-01 | 0.025 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.454623e-01 | 0.024 | 1 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.469754e-01 | 0.024 | 1 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.485729e-01 | 0.023 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.493522e-01 | 0.023 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.497450e-01 | 0.022 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.497450e-01 | 0.022 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.497450e-01 | 0.022 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.497450e-01 | 0.022 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.509021e-01 | 0.022 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.526448e-01 | 0.021 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.532422e-01 | 0.021 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.532510e-01 | 0.021 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.536554e-01 | 0.021 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.543711e-01 | 0.020 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.543711e-01 | 0.020 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.543711e-01 | 0.020 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.543711e-01 | 0.020 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.545202e-01 | 0.020 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.558951e-01 | 0.020 | 1 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.568455e-01 | 0.019 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.568455e-01 | 0.019 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.574491e-01 | 0.019 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.585716e-01 | 0.018 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.585716e-01 | 0.018 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.585716e-01 | 0.018 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.585716e-01 | 0.018 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.589356e-01 | 0.018 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.591805e-01 | 0.018 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.601820e-01 | 0.018 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.601820e-01 | 0.018 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.610780e-01 | 0.017 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.623856e-01 | 0.017 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.623856e-01 | 0.017 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.623856e-01 | 0.017 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.623856e-01 | 0.017 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.623856e-01 | 0.017 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.655122e-01 | 0.015 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.655122e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.656696e-01 | 0.015 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.656696e-01 | 0.015 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.656696e-01 | 0.015 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.658487e-01 | 0.015 | 1 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.658487e-01 | 0.015 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.667744e-01 | 0.015 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.669179e-01 | 0.015 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.687702e-01 | 0.014 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.689932e-01 | 0.014 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.689932e-01 | 0.014 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.689932e-01 | 0.014 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.689932e-01 | 0.014 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.712136e-01 | 0.013 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.718483e-01 | 0.012 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.718483e-01 | 0.012 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.732853e-01 | 0.012 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.733699e-01 | 0.012 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.734189e-01 | 0.012 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.734721e-01 | 0.012 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.752460e-01 | 0.011 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.753023e-01 | 0.011 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.753413e-01 | 0.011 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.764637e-01 | 0.010 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.767944e-01 | 0.010 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.767944e-01 | 0.010 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.789315e-01 | 0.009 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.789315e-01 | 0.009 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.808720e-01 | 0.008 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.808720e-01 | 0.008 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.808720e-01 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.812403e-01 | 0.008 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.815844e-01 | 0.008 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.817901e-01 | 0.008 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.826338e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.826338e-01 | 0.008 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.836013e-01 | 0.007 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.838256e-01 | 0.007 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.842334e-01 | 0.007 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.842334e-01 | 0.007 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.842334e-01 | 0.007 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.853405e-01 | 0.006 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.856858e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.856858e-01 | 0.006 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.856858e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.856858e-01 | 0.006 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.864064e-01 | 0.006 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.867482e-01 | 0.006 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.870045e-01 | 0.006 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.882017e-01 | 0.005 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.884154e-01 | 0.005 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.884154e-01 | 0.005 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.884901e-01 | 0.005 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.891756e-01 | 0.005 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.892306e-01 | 0.005 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.892738e-01 | 0.005 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.892888e-01 | 0.005 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.893475e-01 | 0.005 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.893582e-01 | 0.005 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.909973e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.909973e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.911717e-01 | 0.004 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.913357e-01 | 0.004 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.919853e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.919853e-01 | 0.003 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.919853e-01 | 0.003 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.923085e-01 | 0.003 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.927239e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.927511e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.931955e-01 | 0.003 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.933945e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.933945e-01 | 0.003 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.940033e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.941050e-01 | 0.003 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.943791e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.945560e-01 | 0.002 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.945560e-01 | 0.002 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.945861e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.949692e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.949692e-01 | 0.002 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.951419e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.954355e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.954355e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.955134e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.958097e-01 | 0.002 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.958097e-01 | 0.002 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.958097e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.958097e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.958253e-01 | 0.002 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.959270e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.960499e-01 | 0.002 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.961538e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.963025e-01 | 0.002 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.966216e-01 | 0.001 | 1 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.966434e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.966434e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.966434e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.970277e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.973408e-01 | 0.001 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.975443e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.977056e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.979067e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.979308e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.981216e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.981216e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.982307e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.984098e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.984098e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.985950e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.985950e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.990387e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.990460e-01 | 0.000 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.991450e-01 | 0.000 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.992393e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.992609e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.992865e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.993524e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.994280e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.995157e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.995688e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.996010e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.996010e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.996512e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.996940e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997199e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.997527e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997714e-01 | 0.000 | 1 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.997769e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997865e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998162e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998357e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.998706e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998833e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.998869e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998916e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998972e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999196e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999252e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999386e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999527e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999572e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999585e-01 | 0.000 | 1 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999589e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999627e-01 | 0.000 | 1 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999701e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999751e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999756e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999760e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999785e-01 | 0.000 | 1 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999792e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999833e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999868e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999871e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999878e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999899e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999925e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999942e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999977e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999979e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999986e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999991e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999994e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999995e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999996e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999998e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 1.000000e+00 | 0.000 | 1 | 1 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.000000e+00 | 0.000 | 1 | 1 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.000000e+00 | 0.000 | 1 | 1 |